Breaking News Instant updates and real-time market news.

2023-03-29 09:28:43 SMPL Simply Good Foods $38.57 / -0.45 (-1.15%) 09:28 03/29/23 03/29 09:28 03/29/23 09:28	Simply Good Foods price target raised to $43 from $40 at Stephens Stephens raised the firm's price target on Simply Good Foods to $43 from $40 and keeps an Overweight rating on the shares. Consumption trends at Simply Good have proven to be resilient, which could be a result of Simply Good's product portfolio's better-for-you positioning, the analyst tells investors. If economic conditions deteriorate, brands will have to convince customers their products should be bought, but Simply Good Foods already offers an attractive value proposition to its customers, the firm says.	05 Apr

2023-03-29 09:28:43

SMPL

Simply Good Foods

$38.57 / -0.45 (-1.15%)

09:28

03/29/23

03/29

09:28

03/29/23

09:28

Simply Good Foods price target raised to $43 from $40 at Stephens

Stephens raised the firm's price target on Simply Good Foods to $43 from $40 and keeps an Overweight rating on the shares. Consumption trends at Simply Good have proven to be resilient, which could be a result of Simply Good's product portfolio's better-for-you positioning, the analyst tells investors. If economic conditions deteriorate, brands will have to convince customers their products should be bought, but Simply Good Foods already offers an attractive value proposition to its customers, the firm says.

05
Apr

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Churchill Downs suspends racing after 'unusual number of horse injuries' » 08:38 06/03/23 06/03 08:38 06/03/23 08:38 CHDN Churchill Downs $142.10 / +4.82 (+3.51%) Churchill Downs announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 6th, 08:38 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly CHDN Churchill Downs $142.10 / +4.82 (+3.51%) 06/02/23 Churchill Downs suspends operations at racetrack due to equine deaths 05/31/23 Nevada reports April statewide gaming win up 2.77% to $1.16B 04/25/23 Churchill Downs announces two-for-one stock split 04/25/23 Nevada reports March statewide gaming win down 3.18% to $1.31B CHDN Churchill Downs $142.10 / +4.82 (+3.51%) 04/28/23 JMP Securities Churchill Downs price target raised to $326 from $298 at JMP Securities 04/17/23 JMP Securities Churchill Downs price target raised to $298 from $273 at JMP Securities 03/17/23 Truist Truist starts 'best growth story in gaming' Churchill Downs at Buy 03/17/23 Truist Churchill Downs initiated with a Buy at Truist CHDN Churchill Downs $142.10 / +4.82 (+3.51%) 02/22/23 Churchill Downs reports Q4 adjusted EPS $1.46, consensus $1.67 CHDN Churchill Downs $142.10 / +4.82 (+3.51%) 05/08/23 Seventh horse dies at Churchill Downs ahead of Kentucky Derby, NYT reports CHDN Churchill Downs $142.10 / +4.82 (+3.51%) 06/02/23 Bet On It: Online sports betting bill okayed by Senate in North Carolina 05/26/23 Bet On It: MGM Resorts considered potential buyer for Kindred Group 05/19/23 Bet On It: Fanatics buys U.S. operations from PointsBet 05/12/23 Bet On It: Churchill Downs posts all-time high Kentucky Derby wagers
Conference/Events	BTIG healthcare analysts to hold a reception » 04:55 06/03/23 06/03 04:55 06/03/23 04:55 Healthcare Analysts hold… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 6th, 04:55 Get Free Trial
Hot Stocks	Jazz Pharmaceuticals, Zymeworks report 'positive' Phase 2b HERIZON-BTC-01 data » 18:46 06/02/23 06/02 18:46 06/02/23 18:46 JAZZ Jazz Pharmaceuticals $128.24 / -0.66 (-0.51%) , ZYME Zymeworks $8.67 / +0.18 (+2.12%) Jazz Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 18:46 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ZYME JAZZ ZYME Zymeworks $8.67 / +0.18 (+2.12%) 05/18/23 Zymeworks president, COO Neil Klompas departs 03/30/23 Zymeworks discloses $1.6M purchase of common stock by Ecor1 Capital 01/23/23 Zymeworks shareholder EcoR1 Capital buys $3.0M in company shares JAZZ Jazz Pharmaceuticals $128.24 / -0.66 (-0.51%) 03/02/23 Avadel Pharmaceuticals requests final FDA approval for LUMRYZ 02/28/23 Sutro Biopharma appoints Borgman as Chief Medical Officer 02/24/23 Avadel says Federal Circuit Court of Appeals denied Jazz appeal 01/19/23 Jazz Pharmaceuticals, Zymeworks report 84% survival for zanidatamab in mGEA JAZZ ZYME JAZZ Jazz Pharmaceuticals $128.24 / -0.66 (-0.51%) 05/11/23 RBC Capital Jazz Pharmaceuticals price target lowered to $202 from $207 at RBC Capital 05/11/23 Needham Jazz Pharmaceuticals price target raised to $212 from $205 at Needham 05/02/23 H.C. Wainwright Avadel price target raised to $17.50 from $14 at H.C. Wainwright 12/20/22 Jefferies Zymeworks upgraded to Buy at Jefferies with increased clarity ZYME Zymeworks $8.67 / +0.18 (+2.12%) 05/18/23 Citi Zymeworks price target raised to $18 from $17 at Citi 05/09/23 Stifel Zymeworks price target raised to $19 from $18 at Stifel 03/20/23 Wells Fargo Zymeworks coverage transferred at Wells Fargo with Overweight rating 03/10/23 Citi Zymeworks price target lowered to $17 from $21 at Citi ZYME JAZZ ZYME Zymeworks $8.67 / +0.18 (+2.12%) 05/08/23 Zymeworks reports Q1 adjusted EPS (34c), consensus (54c) 03/07/23 Zymeworks reports Q4 EPS $4.65, consensus $4.84 JAZZ Jazz Pharmaceuticals $128.24 / -0.66 (-0.51%) 05/10/23 Jazz Pharmaceuticals backs FY23 adjusted EPS view $16.90-$17.85 05/10/23 Jazz Pharmaceuticals reports Q1 adjusted EPS $3.95, consensus $4.24 03/01/23 Jazz Pharmaceuticals sees FY23 adjusted EPS $16.90-$17.85, consensus $18.00 03/01/23 Jazz Pharmaceuticals reports Q4 adjusted EPS (7c), consensus 32c ZYME JAZZ ZYME Zymeworks $8.67 / +0.18 (+2.12%) 03/08/23 Fly Intel: Pre-market Movers 01/12/23 Fly Intel: After-Hours Movers 12/19/22 What You Missed On Wall Street On Monday 12/19/22 What You Missed On Wall Street This Morning JAZZ Jazz Pharmaceuticals $128.24 / -0.66 (-0.51%) 12/09/22 What You Missed On Wall Street On Friday 12/09/22 What You Missed On Wall Street This Morning 12/09/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/08/22 Fly Intel: After-Hours Movers 06/05/23 Biotechnology--Dinner 06/02/23 2023 ASCO Annual Meeting
Hot Stocks	ABM CEO Salmirs sells 14,983 common shares » 18:15 06/02/23 06/02 18:15 06/02/23 18:15 ABM ABM $46.23 / +2.125 (+4.82%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 18:15 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ABM ABM $46.23 / +2.125 (+4.82%) 06/02/23 ABM announces shuttle transportation expansion, new bus fleet project at TPA 06/01/23 ABM partners with Ohio-based automotive dealership to increase EV charging 05/30/23 ABM continues twenty-year parking partnership with Orlando International Airport 05/11/23 ABM plans to build EV ecosystem hub ABM ABM $46.23 / +2.125 (+4.82%) 06/01/23 UBS ABM initiated with Neutral on balanced risk/reward at UBS 05/31/23 UBS ABM initiated with a Neutral at UBS 03/09/23 Baird ABM downgraded to Neutral from Outperform at Baird 09/12/22 Baird ABM price target lowered to $52 from $53 at Baird ABM ABM $46.23 / +2.125 (+4.82%) 03/08/23 ABM reaffirms FY23 adjusted EPS $3.40-$3.60, consensus $3.52 03/08/23 ABM reports Q1 adjusted EPS 79c, consensus 77c 12/13/22 ABM sees FY23 adjusted EPS $3.40-$3.60, consensus $3.66 12/13/22 ABM reports Q4 adjusted EPS 89c, consensus 88c ABM ABM $46.23 / +2.125 (+4.82%) 12/14/22 What You Missed On Wall Street On Wednesday 12/14/22 What You Missed On Wall Street This Morning 12/13/22 Fly Intel: After-Hours Movers 06/06/23 ABM - ABM
Conference/Events	Oppenheimer biotech analyst to hold a reception » 17:55 06/02/23 06/02 17:55 06/02/23 17:55 AGEN Agenus $1.62 / +0.025 (+1.57%) , CGEN Compugen $1.04 / +0.03 (+2.97%) , DAWN Day One Biopharmaceuticals $13.60 / -0.04 (-0.29%) , ERAS Erasca $2.91 / +0.215 (+7.99%) , IMRX Immuneering $8.66 / -0.64 (-6.88%) , KNTE Kinnate Biopharma $4.22 / -0.1 (-2.31%) , MRTX Mirati Therapeutics $38.18 / +1.12 (+3.02%) , RVMD Revolution Medicines $25.54 / +0.37 (+1.47%) , VIRX Viracta Therapeutics $1.45 / +0.05 (+3.57%) , ONCT Oncternal Therapeutics / + , BMEA Biomea Fusion $35.79 / +0.185 (+0.52%) , MRNA Moderna $130.52 / +1.99 (+1.55%) , REGN Regeneron $740.00 / +8.995 (+1.23%) , AZN AstraZeneca $72.57 / -0.27 (-0.37%) , GILD Gilead $77.88 / +1.665 (+2.18%) , VSTM Verastem $11.90 / +0.07 (+0.59%) , SWTX SpringsWorks Therapeutics $27.33 / -0.34 (-1.23%) Biotech Analysts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 17:55 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options VSTM VIRX SWTX RVMD REGN ONCT MRTX MRNA KNTE IMRX GILD ERAS DAWN CGEN BMEA AZN AGEN VSTM Verastem $11.90 / +0.07 (+0.59%) 05/31/23 Verastem announces 1-for-12 reverse stock split 05/25/23 Verastem's vutometinib shows 45% response rate in recurrent ovarian cancer 04/26/23 Interim analysis of Verastem's RAMP 201 trial to be presented at ASCO 01/24/23 Verastem reports interim data from Part A of the ongoing RAMP 201 Phase 2 study VIRX Viracta Therapeutics $1.45 / +0.05 (+3.57%) 05/02/23 Viracta Therapeutics CMO Lisa Rojkjaer, M.D to depart 01/19/23 Viracta Therapeutics announces EC orphan drug designation for Nana-val 01/08/23 Viracta announces first clinical response in EBV+ solid tumor setting SWTX SpringsWorks Therapeutics $27.33 / -0.34 (-1.23%) 05/30/23 SpringsWorks Therapeutics says Phase 2 nirogacestat trial fully enrolled 04/17/23 MapKure, SpringWorks, BeiGene present data from Phase 1a/1b study of BGB-3245 02/27/23 SpringsWorks announces FDA acceptance, priority review of nirogacestat NDA 12/27/22 SpringsWorks Therapeutics completes submission of nirogacestat NDA to FDA RVMD Revolution Medicines $25.54 / +0.37 (+1.47%) 12/19/22 Revolution Medicines announces publication on design, synthesis of RMC-5552 12/07/22 Revolution to regain rights to RMC-4630 following Sanofi deal termination 12/07/22 Sanofi terminates SHP2 Inhibitor development pact with Revolution Medicines REGN Regeneron $740.00 / +8.995 (+1.23%) 05/25/23 Regeneron says updated Linvoseltamab data demonstrates durable responses 05/25/23 Regeneron reports 'positive' data from Fianlimab-Libtayo combo trial 05/21/23 Regeneron, Sanofi present Dupixent late-breaking Phase 3 COPD results 05/18/23 Sanofi 'pleased' with Supreme Court's ruling on Amgen's asserted patent claims ONCT Oncternal Therapeutics / + 04/03/23 Oncternal Therapeutics falls 41% to 46c per share after drug development halt 04/03/23 Oncternal Therapeutics trading resumes 04/03/23 Oncternal Therapeutics to resume trading at 4:30pm ET 04/03/23 Oncternal Therapeutics halts development of zilovertamab, ibrutinib combination MRTX Mirati Therapeutics $38.18 / +1.12 (+3.02%) 05/24/23 Mirati Therapeutics falls 10% after SAPPHIRE study did not meet primary endpoint 05/24/23 Mirati Therapeutics trading resumes 05/24/23 Mirati Therapeutics says SAPPHIRE study did not meet primary endpoint 05/24/23 Mirati Therapeutics trading halted, news pending MRNA Moderna $130.52 / +1.99 (+1.55%) 05/23/23 Moderna, BioNTech other Covid vaccine makers jump amid China Covid scare 05/19/23 Moderna reports interim data from Phase 1/2 trial of mRNA-3927 05/04/23 Moderna up 5% after Q1 results beat estimates 05/04/23 Moderna, Novocol Pharma enter long-term fill-finish agreement KNTE Kinnate Biopharma $4.22 / -0.1 (-2.31%) 04/17/23 Kinnate Biopharma adds two candidates to pipeline, provides cash runway guidance 04/17/23 Kinnate Biopharma announces 'positive' monotherapy dose escalation data 02/21/23 Kinnate Biopharma acquires ownership stake of Kinnjiu Biopharma for $24M 02/14/23 Kinnate Biopharma granted fast track designation for KIN-3248 from FDA IMRX Immuneering $8.66 / -0.64 (-6.88%) 04/18/23 Immuneering down 5% at $11.53 after pricing $30M stock offering 04/18/23 Immuneering announces initial Phase 1 PK, PD, safety data for IMM-1-104 03/28/23 Immuneering appoints Harold Brakewood as CBO 03/05/23 Immuneering presents preclinical data with lead program IMM-1-104 GILD Gilead $77.88 / +1.665 (+2.18%) 05/26/23 Gilead announces CHMP reccomendation for the use of Veklury 05/17/23 Gilead to present advances across its oncology pipeline at ASCO Annual Meeting 05/15/23 Arcus Biosciences jumps 2% amid expanded inflammation pact with Gilead 05/15/23 Expanded Gilead- Arcus pact may result in up to $1B in payments to Arcus ERAS Erasca $2.91 / +0.215 (+7.99%) 05/25/23 Erasca to present HERKULES-3 phase 1b data for ERAS-007 at ASCO 05/16/23 Erasca appoints Davd Chacko as CBO, Nik Chetwyn as COO 05/01/23 Erasca announces U.S. FDA granted FTD to ERAS-801 04/25/23 Erasca announces publication of clinical data on naporafenib DAWN Day One Biopharmaceuticals $13.60 / -0.04 (-0.29%) 01/08/23 Day One announces top line data from pivotal Phase 2 FIREFLY-1 trial CGEN Compugen $1.04 / +0.03 (+2.97%) 03/06/23 Compugen doses first patient in proof-of-concept study evaluating COM701 02/14/23 Compugen: Rilvegostomig expected to progress into Phase 3 this year 12/06/22 Compugen's COM701 shows durable anti-tumor activity in ovarian cancer BMEA Biomea Fusion $35.79 / +0.185 (+0.52%) 05/01/23 Biomea says FDA clearance of IND application to begin Phase I trial of BMF-500 04/19/23 Biomea Fusion to present late breaking data from Phase II trial, COVALENT-111 03/28/23 Biomea Fusion trading resumes 03/28/23 Biomea Fusion trading halted, volatility trading pause AZN AstraZeneca $72.57 / -0.27 (-0.37%) 06/02/23 AstraZeneca's IMFINZI plus chemo improved pathologic response in Phase III trial 06/02/23 AstraZeneca says Imfinzi plus chemotherapy showed clinical benefit in trial 06/01/23 AstraZeneca, Merck announce LYNPARZA + abiraterone approved for BRCAm cancer 06/01/23 Merck and AstraZeneca's Lynparza prostate cancer combination approved by FDA AGEN Agenus $1.62 / +0.025 (+1.57%) 05/03/23 Agenus up 4% after FDA approves GSK's Arexvy RSV vaccine 04/26/23 Agenus to present Phase 1, Phase 2 trial data at ASCO meeting 04/17/23 Agenus receives Fast Track Designation from FDA for botensilimab, balstilimab 03/27/23 Agenus announces results from cohort in study of botensilimab with balstilimab AGEN CGEN DAWN ERAS IMRX KNTE MRTX RVMD VIRX ONCT BMEA MRNA REGN AZN GILD VSTM SWTX AGEN Agenus $1.62 / +0.025 (+1.57%) 05/25/23 EF Hutton Agenus assumed with a Buy at EF Hutton 05/09/23 H.C. Wainwright Agenus's progress continues with data presentations, says H.C. Wainwright 04/20/23 B. Riley B. Riley came away 'encouraged' on Agenus after AACR 02/28/23 H.C. Wainwright Agenus assumed with a Buy at H.C. Wainwright CGEN Compugen $1.04 / +0.03 (+2.97%) 02/08/23 Jefferies Compugen downgraded to Underperform from Hold at Jefferies 01/04/23 EF Hutton Compugen initiated with a Buy at EF Hutton 11/14/22 Oppenheimer Compugen price target lowered to $8 from $12 at Oppenheimer 08/23/22 Truist Compugen price target lowered to $4 from $14 at Truist DAWN Day One Biopharmaceuticals $13.60 / -0.04 (-0.29%) 05/01/23 Oppenheimer Day One language around NDA submission 'sounded ominous,' says Oppenheimer 05/01/23 H.C. Wainwright Day One pullback brings attractive entry point, says H.C. Wainwright 04/25/23 BofA Day One Biopharmaceuticals double downgraded at BofA on regulatory risks 04/25/23 BofA Day One Biopharmaceuticals downgraded to Underperform from Buy at BofA ERAS Erasca $2.91 / +0.215 (+7.99%) 03/29/23 Mizuho Erasca initiated with a Buy at Mizuho 02/24/23 Goldman Sachs Erasca initiated with a Buy at Goldman Sachs 02/03/23 Morgan Stanley Erasca upgraded to Overweight from Equal Weight at Morgan Stanley IMRX Immuneering $8.66 / -0.64 (-6.88%) 04/19/23 Mizuho Immuneering upgraded to Buy from Neutral at Mizuho 04/19/23 Morgan Stanley Immuneering upgraded to Equal Weight from Underweight at Morgan Stanley 04/18/23 Chardan Immuneering price target raised to $22 from $18 at Chardan 03/29/23 Mizuho Immuneering initiated with a Neutral at Mizuho KNTE Kinnate Biopharma $4.22 / -0.1 (-2.31%) 05/18/23 H.C. Wainwright Kinnate Biopharma price target lowered to $24 from $25 at H.C. Wainwright 04/20/23 H.C. Wainwright Kinnate Biopharma price target lowered to $25 from $33 at H.C. Wainwright 04/18/23 Stifel Kinnate Biopharma price target lowered to $5 from $8 at Stifel 04/18/23 Wedbush Kinnate Biopharma price target lowered to $14 from $25 at Wedbush MRTX Mirati Therapeutics $38.18 / +1.12 (+3.02%) 05/25/23 Oppenheimer Oppenheimer upgrades Mirati to Outperform with Krazati expectations reset 05/25/23 Oppenheimer Mirati Therapeutics upgraded to Outperform from Perform at Oppenheimer 05/25/23 BMO Capital Mirati Therapeutics price target lowered to $40 from $50 at BMO Capital 05/25/23 Barclays Mirati Therapeutics price target lowered to $75 from $90 at Barclays RVMD Revolution Medicines $25.54 / +0.37 (+1.47%) 05/09/23 JPMorgan Revolution Medicines price target lowered to $35 from $38 at JPMorgan 02/28/23 Needham Revolution Medicines price target raised to $38 from $32 at Needham 02/28/23 Oppenheimer Revolution Medicines price target raised to $35 from $30 at Oppenheimer 02/28/23 JPMorgan Revolution Medicines upgraded to Overweight from Neutral at JPMorgan VIRX Viracta Therapeutics $1.45 / +0.05 (+3.57%) 05/10/23 H.C. Wainwright Viracta Therapeutics price target lowered to $33 from $35 at H.C. Wainwright ONCT Oncternal Therapeutics / + 04/06/23 Cantor Fitzgerald Oncternal downgraded to Neutral from Overweight at Cantor Fitzgerald 04/04/23 Maxim Oncternal Therapeutics downgraded to Hold from Buy at Maxim 04/04/23 Cantor Fitzgerald Oncternal Therapeutics price target lowered to $1.30 from $4.00 at Cantor Fitzgerald 04/04/23 H.C. Wainwright Oncternal Therapeutics downgraded to Neutral from Buy at H.C. Wainwright BMEA Biomea Fusion $35.79 / +0.185 (+0.52%) 05/25/23 EF Hutton Biomea Fusion assumed with a Buy at EF Hutton 05/18/23 Citi Biomea Fusion price target lowered to $53 from $55 at Citi 05/12/23 Barclays Biomea Fusion initiated with an Overweight at Barclays 04/19/23 H.C. Wainwright Biomea Fusion price target lowered to $37 from $44 at H.C. Wainwright MRNA Moderna $130.52 / +1.99 (+1.55%) 05/31/23 Jefferies Carisma Therapeutics assumed at Buy from Hold at Jefferies 05/05/23 Morgan Stanley Moderna price target lowered to $153 from $185 at Morgan Stanley 04/25/23 Guggenheim Moderna initiated with a Neutral at Guggenheim 04/13/23 Baird Carisma Therapeutics initiated with an Outperform at Baird REGN Regeneron $740.00 / +8.995 (+1.23%) 05/19/23 Piper Sandler Regeneron Q1 Eylea miss 'not about share, says Piper Sandler 05/08/23 Guggenheim Regeneron price target lowered to $935 from $960 at Guggenheim 05/05/23 Morgan Stanley Regeneron price target raised to $927 from $880 at Morgan Stanley 05/05/23 SVB Securities Regeneron price target lowered to $895 from $976 at SVB Securities AZN AstraZeneca $72.57 / -0.27 (-0.37%) 05/26/23 Argus AstraZeneca price target lowered to $80 from $85 at Argus 05/09/23 Berenberg AstraZeneca price target raised to 135 GBp from 124 GBp at Berenberg 04/28/23 JPMorgan AstraZeneca price target raised to 14,000 GBp from 13,500 GBp at JPMorgan 04/13/23 Argus AstraZeneca price target raised to $85 from $75 at Argus GILD Gilead $77.88 / +1.665 (+2.18%) 06/02/23 Argus Gilead continues to make regulatory progress, says Argus 05/16/23 BMO Capital Gilead upgraded to Outperform from Market Perform at BMO Capital 04/28/23 Piper Sandler Gilead assumed with an Overweight at Piper Sandler 04/12/23 Morgan Stanley Gilead price target raised to $85 from $81 at Morgan Stanley VSTM Verastem $11.90 / +0.07 (+0.59%) 05/10/23 H.C. Wainwright Verastem price target lowered to $2 from $3 at H.C. Wainwright 03/29/23 Mizuho Verastem initiated with a Neutral at Mizuho 11/07/22 H.C. Wainwright Verastem price target lowered to $3 from $5 at H.C. Wainwright 10/05/22 BTIG Verastem price target lowered to $5 from $8 at BTIG SWTX SpringsWorks Therapeutics $27.33 / -0.34 (-1.23%) 04/28/23 Barclays SpringsWorks Therapeutics price target lowered to $41 from $55 at Barclays 03/07/23 H.C. Wainwright SpringsWorks Therapeutics price target raised to $105 from $99 at H.C. Wainwright 01/02/23 Barclays Barclays views GSK acquisition interest as positive for oncology stocks 12/01/22 BofA SpringsWorks Therapeutics initiated with a Buy, $45 price target at BofA VSTM VIRX SWTX RVMD REGN ONCT MRTX MRNA KNTE GILD ERAS DAWN CGEN BMEA AZN AGEN VSTM Verastem $11.90 / +0.07 (+0.59%) 05/09/23 Verastem reports Q1 EPS (9c), consensus (8c) 03/14/23 Verastem reports Q4 EPS (8c), consensus (10c) VIRX Viracta Therapeutics $1.45 / +0.05 (+3.57%) 05/08/23 Viracta Therapeutics reports Q1 EPS (32c), consensus (31c) 03/13/23 Viracta Therapeutics reports Q4 EPS (27c), consensus (38c) SWTX SpringsWorks Therapeutics $27.33 / -0.34 (-1.23%) 05/03/23 SpringsWorks Therapeutics reports Q1 EPS ($1.18), consensus ($1.25) 02/28/23 SpringsWorks Therapeutics reports Q4 EPS ($1.19), consensus ($1.22) RVMD Revolution Medicines $25.54 / +0.37 (+1.47%) 05/08/23 Revolution Medicines reports Q1 EPS (72c), consensus (81c) 02/27/23 Revolution Medicines sees FY23 net loss $335M-$365M 02/27/23 Revolution Medicines reports Q4 EPS (63c), consensus (82c) REGN Regeneron $740.00 / +8.995 (+1.23%) 05/04/23 Regeneron reports Q1 adjusted EPS $10.09, consensus $9.56 02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open ONCT Oncternal Therapeutics / + 05/04/23 Oncternal Therapeutics reports Q1 EPS (20c), consensus (20c) MRTX Mirati Therapeutics $38.18 / +1.12 (+3.02%) 05/09/23 Mirati Therapeutics reports Q1 EPS ($3.18), consensus ($3.55) 02/28/23 Mirati Therapeutics reports Q4 EPS ($3.51), consensus ($3.55) MRNA Moderna $130.52 / +1.99 (+1.55%) 05/04/23 Moderna sees Q2 sales $200M-$300M, consensus $982.37M 02/23/23 Moderna reports Q4 EPS $3.61, consensus $4.67 02/22/23 Notable companies reporting before tomorrow's open KNTE Kinnate Biopharma $4.22 / -0.1 (-2.31%) 05/11/23 Kinnate Biopharma reports Q1 EPS (73c), consensus (73c) GILD Gilead $77.88 / +1.665 (+2.18%) 05/15/23 Gilead: Arcus deal may reduce Gilead's FY23 GAAP and non-GAAP EPS by 2c 04/27/23 Gilead backs FY23 adjusted EPS view $6.60-$7.00, consensus $6.84 04/27/23 Gilead reports Q1 Biktarvy sales up 24% y/y 04/27/23 Gilead Sciences reports Q1 adjusted EPS $1.37, consensus $1.54 ERAS Erasca $2.91 / +0.215 (+7.99%) 05/15/23 Erasca reports Q1 EPS (22c), consensus (31c) 03/23/23 Erasca reports Q4 EPS ($1.06) vs. (26c) last year DAWN Day One Biopharmaceuticals $13.60 / -0.04 (-0.29%) 05/01/23 Day One Biopharmaceuticals reports Q1 EPS (59c), consensus (59c) CGEN Compugen $1.04 / +0.03 (+2.97%) 05/15/23 Compugen reports Q1 EPS (11c), consensus (12c) 03/10/23 Compugen considers exposure to SVB Financial as immaterial 02/27/23 Compugen reports Q4 EPS (4c), consensus (14c) BMEA Biomea Fusion $35.79 / +0.185 (+0.52%) 05/02/23 Biomea Fusion reports Q1 EPS (98c), consensus (81c) 03/28/23 Biomea Fusion reports Q4 EPS (21c), consensus (81c) AZN AstraZeneca $72.57 / -0.27 (-0.37%) 04/27/23 AstraZeneca sees FY23 core EPS up high single to low double-digit percentage 04/27/23 AstraZeneca reports Q1 core EPS $1.92, consensus $1.07 02/09/23 AstraZeneca sees FY23 core EPS up high single to low double-digit percentage 02/09/23 AstraZeneca reports Q4 core EPS $1.38, consensus $1.35 AGEN Agenus $1.62 / +0.025 (+1.57%) 05/09/23 Agenus reports Q1 EPS (22c), consensus (21c) 03/14/23 Agenus reports Q4 EPS (24c), consensus (22c) 18 Apr 30 Mar 03 Mar 09 Dec 20 Jul 15 Jun REGN MRTX MRNA AZN REGN Regeneron $740.00 / +8.995 (+1.23%) 05/17/23 Regeneron CEO backs regulators attempt to block Amgen deal, FT reports MRTX Mirati Therapeutics $38.18 / +1.12 (+3.02%) 05/09/23 Boxer's Davis pitches Mirati Therapeutics as long idea at Sohn MRNA Moderna $130.52 / +1.99 (+1.55%) 05/26/23 Health authorities to target next COVID shot to new strain, WSJ says 05/23/23 China's new Covid surge could result in 65M infections a week, Bloomberg says 03/23/23 Moderna CEO defends $130 price of Covid-19 vaccine, Reuters reports 03/21/23 FDA moving towards authorizing second omicron booster, WSJ reports AZN AstraZeneca $72.57 / -0.27 (-0.37%) 05/19/23 Astra China head says company seeks to 'love the Communist Party,' Reuters says 05/04/23 AstraZeneca chair says increasing CEO's pay wards of rivals, FT reports 04/06/23 GSK unit ordered to pay AstraZeneca royalties on Zejula sales, Reuters says VSTM SWTX RVMD REGN ONCT MRTX MRNA KNTE GILD ERAS DAWN BMEA AZN AGEN VSTM Verastem $11.90 / +0.07 (+0.59%) 06/01/23 Biotech Alert: Searches spiking for these stocks today 03/14/23 Fly Intel: After-Hours Movers SWTX SpringsWorks Therapeutics $27.33 / -0.34 (-1.23%) 04/22/23 Short Report: Bears pare exposure in crypto stocks as bitcoin slumps RVMD Revolution Medicines $25.54 / +0.37 (+1.47%) 02/28/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations REGN Regeneron $740.00 / +8.995 (+1.23%) 03/28/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/27/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/24/23 What You Missed On Wall Street On Friday 03/24/23 What You Missed On Wall Street This Morning ONCT Oncternal Therapeutics / + 04/06/23 Biotech Alert: Searches spiking for these stocks today 04/04/23 Fly Intel: Pre-market Movers 04/03/23 Fly Intel: After-Hours Movers 12/07/22 Biotech Alert: Searches spiking for these stocks today MRTX Mirati Therapeutics $38.18 / +1.12 (+3.02%) 06/02/23 Biotech Alert: Searches spiking for these stocks today 05/25/23 Fly Intel: Pre-market Movers 02/19/23 Short Report: Bearish bets in crypto arena renewed as coins and stocks rebound 12/31/22 Short Report: Bearish views reach record high on Silvergate, Mirati Therapeutics MRNA Moderna $130.52 / +1.99 (+1.55%) 04/26/23 What You Missed On Wall Street On Wednesday 04/26/23 What You Missed On Wall Street This Morning 04/14/23 Biotech Alert: Searches spiking for these stocks today 04/13/23 Biotech Alert: Searches spiking for these stocks today KNTE Kinnate Biopharma $4.22 / -0.1 (-2.31%) 05/15/23 Fly Insider: Kinnate Biopharma, Arrowhead among week's notable insider trades GILD Gilead $77.88 / +1.665 (+2.18%) 05/16/23 What You Missed On Wall Street On Tuesday 05/16/23 What You Missed On Wall Street This Morning 05/16/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/28/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations ERAS Erasca $2.91 / +0.215 (+7.99%) 03/23/23 Fly Intel: After-Hours Movers 02/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/09/22 What You Missed On Wall Street On Friday 12/09/22 What You Missed On Wall Street This Morning DAWN Day One Biopharmaceuticals $13.60 / -0.04 (-0.29%) 04/28/23 Buy/Sell: Wall Street's top 10 stock calls this week 04/25/23 What You Missed On Wall Street On Tuesday 04/25/23 What You Missed On Wall Street This Morning 04/25/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations BMEA Biomea Fusion $35.79 / +0.185 (+0.52%) 04/10/23 Fly Insider: Planet Labs, C3.ai among week's notable insider trades 03/28/23 What You Missed On Wall Street On Tuesday 03/28/23 What You Missed On Wall Street This Morning AZN AstraZeneca $72.57 / -0.27 (-0.37%) 04/11/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/05/23 What You Missed On Wall Street On Wednesday 04/05/23 What You Missed On Wall Street This Morning 02/09/23 What You Missed On Wall Street This Morning AGEN Agenus $1.62 / +0.025 (+1.57%) 04/17/23 What You Missed On Wall Street On Monday 04/17/23 What You Missed On Wall Street This Morning 01/23/23 What You Missed On Wall Street On Monday 01/23/23 What You Missed On Wall Street This Morning 06/02/23 Biotechnology--Pre-ASCO Reception 06/05/23 Biotechnology--Dinner 06/09/23 Biotechnology 06/12/23 Biotech/Biopharma 06/02/23 2023 ASCO Annual Meeting 09/19/23 Institutional Investor Conference 2023 06/27/23 PDUFA Date for Eylea 08/20/23 PDUFA Date for Pozelimab 08/27/23 PDUFA Date for Nirogacestat 12/22/23 PDUFA Date for Eplontersen 06/08/23 Revolution Medicines, Inc. 06/08/23 Viracta Therapeutics Inc 06/09/23 Regeneron Pharmaceuticals 06/09/23 Kinnate Biopharma Inc. 06/12/23 Agenus Inc. 06/13/23 Compugen 06/14/23 Compugen 06/14/23 Immuneering Corp. 06/14/23 BioMea Fusion, Inc. 06/15/23 Compugen 06/22/23 Day One Biopharmaceuticals, Inc 06/22/23 Erasca, Inc. 06/28/23 Oncternal Therapeutics Inc REGN MRNA GILD BMEA AZN REGN Regeneron $740.00 / +8.995 (+1.23%) 03/23/23 Early notable gainers among liquid option names on March 23rd MRNA Moderna $130.52 / +1.99 (+1.55%) 05/24/23 Unusually active option classes on open May 24th 05/23/23 Moderna call volume above normal and directionally bullish 05/23/23 Early notable gainers among liquid option names on May 23rd 04/17/23 Unusually active option classes on open April 17th GILD Gilead $77.88 / +1.665 (+2.18%) 05/25/23 Gilead call volume above normal and directionally bullish 05/03/23 Gilead call volume above normal and directionally bullish 04/27/23 Gilead options imply 3.8% move in share price post-earnings 02/03/23 Early notable gainers among liquid option names on February 3rd BMEA Biomea Fusion $35.79 / +0.185 (+0.52%) 03/28/23 Biomea Fusion options imply 11.3% move in share price post-earnings AZN AstraZeneca $72.57 / -0.27 (-0.37%) 05/26/23 Unusually active option classes on open May 26th 05/18/23 Unusually active option classes on open May 18th 05/09/23 AstraZeneca put volume heavy and directionally bearish 04/27/23 Unusually active option classes on open April 27th
Hot Stocks	Palo Alto Networks jumps 5% to $228.50 after inclusion in S&P 500 17:46 06/02/23 06/02 17:46 06/02/23 17:46 PANW Palo Alto Networks $217.23 / +0.475 (+0.22%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PANW Palo Alto Networks $217.23 / +0.475 (+0.22%) 06/02/23 Palo Alto Networks to replace Dish in S&P 500 at open on 6/20 05/23/23 Palo Alto Networks expects supply chains to normalize exiting FY23 05/23/23 Palo Alto Networks says deal scrutiny has increased 05/23/23 Palo Alto Networks sees FY23 adjusted free cash flow margin 37.5%-38.5% PANW Palo Alto Networks $217.23 / +0.475 (+0.22%) 06/02/23 Stephens SentinelOne downgraded to Equal Weight from Overweight at Stephens 05/30/23 RBC Capital Crowdstrike price target raised to $180 from $170 at RBC Capital 05/24/23 Deutsche Bank Palo Alto Networks price target raised to $225 from $210 at Deutsche Bank 05/24/23 Loop Capital Palo Alto Networks price target raised to $240 from $225 at Loop Capital PANW Palo Alto Networks $217.23 / +0.475 (+0.22%) 05/23/23 Palo Alto Networks raises FY23 adjusted EPS view to $4.25-$4.29 from $3.97-$4.03 05/23/23 Palo Alto Networks sees Q4 adjusted EPS $1.26-$1.30, consensus $1.20 05/23/23 Palo Alto Networks reports Q3 adjusted EPS $1.10, consensus 93c 05/23/23 Notable companies reporting after market close PANW Palo Alto Networks $217.23 / +0.475 (+0.22%) 03/15/23 Microsoft says Russia's spring offensive may include new cyberattacks, NYT says 01/06/23 White House to unveil cybersecurity strategy, Washington Post reports PANW Palo Alto Networks $217.23 / +0.475 (+0.22%) 05/24/23 What You Missed On Wall Street On Wednesday 05/24/23 What You Missed On Wall Street This Morning 05/24/23 Fly Intel: Pre-market Movers 05/23/23 Fly Intel: After-Hours Movers PANW Palo Alto Networks $217.23 / +0.475 (+0.22%) 06/01/23 Unusually active option classes on open June 1st 05/23/23 Palo Alto Networks options imply 6.8% move in share price post-earnings 02/21/23 Palo Alto Networks options imply 6.7% move in share price post-earnings
Hot Stocks	Zimmer Energy Transition announces redemption of public shares » 17:43 06/02/23 06/02 17:43 06/02/23 17:43 ZT Zimmer Energy Transition $10.23 / + (+0.00%) Zimmer Energy Transition… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 17:43 Get Free Trial
Hot Stocks	Procore CLO Singer sells 8,147 common shares » 17:42 06/02/23 06/02 17:42 06/02/23 17:42 PCOR Procore $63.14 / +1.15 (+1.86%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 17:42 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PCOR Procore $63.14 / +1.15 (+1.86%) 05/25/23 Procore CEO sells $1.69M in common stock 03/03/23 Procore CLO Singer sells 8,390 common shares 02/21/23 Procore announces Sarah Hodges as CMO, effective immediately 02/16/23 Procore CFO Layndres to assume role of President of Fintech PCOR Procore $63.14 / +1.15 (+1.86%) 05/04/23 Stifel Procore price target lowered to $67 from $79 at Stifel 05/04/23 Goldman Sachs Procore upgraded to Buy from Neutral at Goldman Sachs 05/04/23 MoffettNathanson Procore price target raised to $88 from $80 at MoffettNathanson 04/19/23 KeyBanc Procore price target lowered to $76 from $86 at KeyBanc PCOR Procore $63.14 / +1.15 (+1.86%) 05/03/23 Procore sees FY23 revenue $908M-$912M, consensus $895.1M 05/03/23 Procore sees Q2 revenue $216M-$218M, consensus $15.8M 05/03/23 Procore reports Q1 EPS (45c), consensus (12c) 02/16/23 Procore sees FY23 revenue $895M-$900M, consensus $869.21M PCOR Procore $63.14 / +1.15 (+1.86%) 02/16/23 Fly Intel: After-Hours Movers 06/07/23 Procore Technologies, Inc.
Hot Stocks	S&P DJI announces changes to S&P 600 at open on 6/20 » 17:36 06/02/23 06/02 17:36 06/02/23 17:36 APAM Artisan Partners $33.16 / +1 (+3.11%) , CRC California Resources $39.35 / +1.465 (+3.87%) , CARG CarGurus $19.50 / +0.385 (+2.01%) , MC Moelis $39.78 / +1.63 (+4.27%) , PECO Phillips Edison $30.19 / +1.155 (+3.98%) , SDGR Schrodinger $35.65 / +0.57 (+1.62%) , UFPT UFP Technologies $159.61 / +1.61 (+1.02%) , TREE LendingTree $20.03 / +1.45 (+7.80%) , TG Tredegar $7.67 / +0.43 (+5.94%) , INGN Inogen $10.82 / +0.45 (+4.34%) , DOUG Douglas Elliman $2.94 / +0.08 (+2.80%) , FARO Faro Technologies $15.81 / +0.52 (+3.40%) , CARA Cara Therapeutics $3.09 / -0.005 (-0.16%) , BIG Big Lots $6.08 / +1.21 (+24.87%) Artisan Partners Asset… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 17:36 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options UFPT TREE TG SDGR MC INGN FARO DOUG CRC CARG CARA BIG APAM UFPT UFP Technologies $159.61 / +1.61 (+1.02%) 05/11/23 UFP Technologies CFO Lataille sells 7,354 common shares TREE LendingTree $20.03 / +1.45 (+7.80%) 05/02/23 Shares of LendingTree fall 28% after Q1 results and lowered guidance 03/29/23 LendingTree announces 13% workforce reduction plan 03/06/23 LendingTree repurchases $190M of Convertible Senior Notes due 2025 02/01/23 LendingTree CEO buys $705.7K in common stock TG Tredegar $7.67 / +0.43 (+5.94%) 05/08/23 Tredegar falls -14.3% 01/09/23 Tredegar chairman of the board John Gottwald to retire SDGR Schrodinger $35.65 / +0.57 (+1.62%) 05/04/23 Schrodinger backs FY23 financial guidance 03/22/23 Schrodinger reports inducement grants under Nasdaq Listing Rule 02/28/23 Schrodinger sees FY23 software revenue growth 13%-17% 01/20/23 Schrodinger reports inducement grants under Nasdaq Listing Rule MC Moelis $39.78 / +1.63 (+4.27%) 03/09/23 Moelis appoints Elizabeth Crain to Vice Chair, Kate Pilcher Ciafone to COO 03/07/23 Moelis exec Mahmoodzadegan sells 23,323 class A shares 02/13/23 Moelis exec sold $4.4M in common stock INGN Inogen $10.82 / +0.45 (+4.34%) 01/10/23 Inogen achieves regulatory milestones to support portable oxygen products FARO Faro Technologies $15.81 / +0.52 (+3.40%) 05/03/23 Faro Technologies CEO Michael Burger to retire, Yuval Wasserman interim CEO DOUG Douglas Elliman $2.94 / +0.08 (+2.80%) 01/30/23 Douglas Elliman promotes Deva Roberts to general counsel CRC California Resources $39.35 / +1.465 (+3.87%) 05/01/23 California Resources names Manuela Molina CFO 02/24/23 CRC CEO Mark McFarland to switch roles, Francisco Leon to succeed 02/24/23 California Resources sees FY23 capital program $200M-$245M 02/24/23 California Resources sees Q1 capital program $57M-$69M CARG CarGurus $19.50 / +0.385 (+2.01%) 12/08/22 CarGurus announces $250M share repurchase program CARA Cara Therapeutics $3.09 / -0.005 (-0.16%) 05/18/23 Cara announces NICE recommends Kapruvia for CKD-associated pruritus treatment 03/10/23 Cara Therapeutics says it does not hold cash deposits, securities at SVB 03/06/23 Cara sees cash, cash equivalents sufficient to fund ops into at least 1H24 02/08/23 Cara Therapeutics announces results from Phase 2 trial of oral Difelikefalin BIG Big Lots $6.08 / +1.21 (+24.87%) 06/02/23 Big Lots rises 20.5% 06/02/23 Big Lots rises 23.2% 06/02/23 Big Lots rises 15.1% 05/30/23 Big Lots falls -11.8% APAM Artisan Partners $33.16 / +1 (+3.11%) 05/09/23 Artisan Partners reports April AUM $138.4B 04/12/23 Artisan Partners reports preliminary AUM $138.5B as of March 31 03/09/23 Artisan Partners reports February AUM $134.8B 01/11/23 Artisan Partners preliminary AUM as of December 31 $127.9B APAM CRC CARG MC PECO SDGR UFPT TREE TG INGN DOUG FARO CARA BIG APAM Artisan Partners $33.16 / +1 (+3.11%) 03/06/23 Goldman Sachs Artisan Partners downgraded to Sell at Goldman on performance challenges 03/06/23 Goldman Sachs Artisan Partners downgraded to Sell from Neutral at Goldman Sachs 01/31/23 RBC Capital Artisan Partners price target raised to $39 from $35 at RBC Capital 10/18/22 Credit Suisse Artisan Partners initiated with a Neutral at Credit Suisse CRC California Resources $39.35 / +1.465 (+3.87%) 05/19/23 Stifel California Resources price target lowered to $50 from $52 at Stifel 05/19/23 Mizuho California Resources price target lowered to $52 from $54 at Mizuho 03/30/23 Stifel California Resources price target lowered to $52 from $64 at Stifel 03/10/23 Mizuho California Resources price target lowered to $54 from $59 at Mizuho CARG CarGurus $19.50 / +0.385 (+2.01%) 05/12/23 Oppenheimer CarGurus price target raised to $24 from $21 at Oppenheimer 05/10/23 DA Davidson CarGurus price target raised to $20 from $18 at DA Davidson 03/01/23 Raymond James CarGurus price target raised to $20 from $16 at Raymond James 03/01/23 Citi CarGurus price target raised to $18 from $14 at Citi MC Moelis $39.78 / +1.63 (+4.27%) 04/12/23 Morgan Stanley Moelis price target lowered to $29 from $30 at Morgan Stanley 01/10/23 Goldman Sachs Moelis downgraded to Sell from Neutral at Goldman Sachs 01/02/23 Keefe Bruyette Moelis transferred with Underperform rating at Keefe Bruyette 01/02/23 Keefe Bruyette Evercore upgraded to Outperform from Market Perform at Keefe Bruyette PECO Phillips Edison $30.19 / +1.155 (+3.98%) 05/25/23 Mizuho Phillips Edison price target lowered to $30 from $35 at Mizuho 05/23/23 Wells Fargo Phillips Edison initiated with an Equal Weight at Wells Fargo 03/21/23 Goldman Sachs Phillips Edison resumed with a Buy at Goldman Sachs 03/01/23 Mizuho Phillips Edison price target raised to $35 from $33 at Mizuho SDGR Schrodinger $35.65 / +0.57 (+1.62%) 05/08/23 Citi Schrodinger price target lowered to $50 from $52 at Citi 05/05/23 Piper Sandler Schrodinger assumed with an Overweight at Piper Sandler 03/01/23 BMO Capital Schrodinger price target lowered to $78 from $83 at BMO Capital 01/31/23 Citi Schrodinger price target raised to $51 from $48 at Citi UFPT UFP Technologies $159.61 / +1.61 (+1.02%) 05/03/23 Lake Street UFP Technologies price target raised to $171 from $131 at Lake Street 03/08/23 Lake Street UFP Technologies price target raised to $131 from $124 at Lake Street 12/21/22 Lake Street UFP Technologies assumed with a Buy at Lake Street 06/22/22 Lake Street UFP Technologies initiated with a Buy at Lake Street TREE LendingTree $20.03 / +1.45 (+7.80%) 05/03/23 Truist LendingTree price target lowered to $27 from $42 at Truist 05/03/23 Northland LendingTree price target lowered to $24 from $35 at Northland 05/03/23 Susquehanna LendingTree price target lowered to $17 from $36 at Susquehanna 02/28/23 BofA LendingTree price target lowered to $43 from $53 at BofA TG Tredegar $7.67 / +0.43 (+5.94%) INGN Inogen $10.82 / +0.45 (+4.34%) 02/24/23 Needham Inogen price target lowered to $26 from $36 at Needham 01/17/23 William Blair Inogen downgraded to Market Perform from Outperform at William Blair DOUG Douglas Elliman $2.94 / +0.08 (+2.80%) FARO Faro Technologies $15.81 / +0.52 (+3.40%) 05/05/23 Baird Faro Technologies price target lowered to $21 from $32 at Baird 05/04/23 Craig-Hallum Faro Technologies price target lowered to $22 from $30 at Craig-Hallum 02/16/23 Needham Faro Technologies price target lowered to $35 from $39 at Needham 08/04/22 Needham Faro Technologies price target lowered to $40 from $50 at DA Davidson CARA Cara Therapeutics $3.09 / -0.005 (-0.16%) 05/16/23 BofA Cara Therapeutics price target lowered to $4 from $6 at BofA 05/16/23 H.C. Wainwright Cara Therapeutics price target lowered to $15 from $20 at H.C. Wainwright 03/07/23 BofA Cara Therapeutics downgraded to Underperform from Neutral at BofA 03/07/23 Needham Cara Therapeutics price target lowered to $22 from $26 at Needham BIG Big Lots $6.08 / +1.21 (+24.87%) 05/31/23 Goldman Sachs Big Lots price target lowered to $5 from $14 at Goldman Sachs 05/30/23 Deutsche Bank Big Lots price target lowered to $6 from $8 at Deutsche Bank 05/30/23 Loop Capital Big Lots price target lowered to $6 from $14 at Loop Capital 04/21/23 Piper Sandler Big Lots downgraded to Underweight from Neutral at Piper Sandler UFPT TREE SDGR PECO MC INGN FARO DOUG CRC CARG CARA BIG APAM UFPT UFP Technologies $159.61 / +1.61 (+1.02%) 05/02/23 UFP Technologies reports Q1 EPS $1.27 vs 64c last year 03/07/23 UFP Technologies reports Q4 EPS $1.10 vs 42c last year TREE LendingTree $20.03 / +1.45 (+7.80%) 05/02/23 LendingTree cuts FY23 revenue view to $760M-$800M from $935M-$985M 05/02/23 LendingTree sees Q2 revenue $190M-$200M, consensus $244.27M 05/02/23 LendingTree reports Q1 adjusted EPS 25c, consensus (10c) 02/27/23 LendingTree sees FY23 revenue $935M-$985M, consensus $985.62M SDGR Schrodinger $35.65 / +0.57 (+1.62%) 05/04/23 Schrodinger reports Q1 EPS $1.75, consensus $1.31 02/28/23 Schrodinger reports Q4 revenue $56.8M, consensus $47.43M PECO Phillips Edison $30.19 / +1.155 (+3.98%) 05/02/23 Phillips Edison reports Q1 EPS 14c, consensus 11c 02/09/23 Phillips Edison reports Q4 EPS 12c, consensus 8c MC Moelis $39.78 / +1.63 (+4.27%) 04/26/23 Moelis reports Q1 EPS 5c, consensus 10c 02/08/23 Moelis reports Q4 adjusted EPS 33c, consensus 33c INGN Inogen $10.82 / +0.45 (+4.34%) 05/04/23 Inogen reports Q1 EPS (88c), consensus (81c) 02/23/23 Inogen reports Q4 EPS ($2.47) vs ($1.01) last year 01/10/23 Inogen sees FY22 revenue $376.7M-$377.7M , consensus $378.6M 01/10/23 Inogen sees Q4 revenue $$87.5M-$88.5M, consensus $89.55M FARO Faro Technologies $15.81 / +0.52 (+3.40%) 05/03/23 Faro Technologies sees Q2 non-GAAP EPS (47c)-(22c), consensus (4c) 05/03/23 Faro Technologies reports Q1 EPS (38c), consensus (13c) 02/15/23 Faro Technologies sees Q1 adjusted EPS (22c)-(2c), consensus (9c) 02/15/23 Faro Technologies reports Q4 adjusted EPS 38c, consensus 34c DOUG Douglas Elliman $2.94 / +0.08 (+2.80%) 03/09/23 Douglas Elliman reports Q4 EPS (24c) vs. 26c last year CRC California Resources $39.35 / +1.465 (+3.87%) 05/02/23 California Resources reports Q1 adjusted EPS $2.63, consensus $1.96 02/24/23 California Resources reports Q4 adjusted EPS $1.24, consensus $1.55 CARG CarGurus $19.50 / +0.385 (+2.01%) 05/09/23 CarGurus sees Q2 EPS 22c-25c, consensus 18c 05/09/23 CarGurus reports Q1 EPS 26c, consensus 17c 02/28/23 CarGurus sees Q1 EPS 17c-19c, consensus 12c 02/28/23 CarGurus reports Q4 EPS 22c, consensus 10c CARA Cara Therapeutics $3.09 / -0.005 (-0.16%) 05/15/23 Cara Therapeutics reports Q1 EPS (49c), consensus (52c) 03/06/23 Cara Therapeutics reports Q4 EPS (56c), consensus (32c) BIG Big Lots $6.08 / +1.21 (+24.87%) 05/26/23 Big Lots reports Q1 adjusted EPS ($3.40), consensus ($1.77) 03/02/23 Big Lots reports Q4 adjusted EPS (28c), consensus (85c) APAM Artisan Partners $33.16 / +1 (+3.11%) 01/31/23 Artisan Partners reports Q4 EPS 65c, consensus 62c TREE SDGR MC FARO CRC CARG CARA BIG TREE LendingTree $20.03 / +1.45 (+7.80%) 03/20/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/28/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations SDGR Schrodinger $35.65 / +0.57 (+1.62%) 05/04/23 Fly Intel: After-Hours Movers 02/28/23 Fly Intel: After-Hours Movers MC Moelis $39.78 / +1.63 (+4.27%) 12/07/22 What You Missed On Wall Street On Wednesday FARO Faro Technologies $15.81 / +0.52 (+3.40%) 01/20/23 What You Missed On Wall Street This Morning CRC California Resources $39.35 / +1.465 (+3.87%) 05/02/23 What You Missed On Wall Street On Tuesday 05/02/23 What You Missed On Wall Street This Morning 02/24/23 Fly Intel: Pre-market Movers CARG CarGurus $19.50 / +0.385 (+2.01%) 05/09/23 Fly Intel: After-Hours Movers 12/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations CARA Cara Therapeutics $3.09 / -0.005 (-0.16%) 05/18/23 Biotech Alert: Searches spiking for these stocks today 05/15/23 Fly Intel: After-Hours Movers 03/08/23 What You Missed On Wall Street On Wednesday 03/08/23 What You Missed On Wall Street This Morning BIG Big Lots $6.08 / +1.21 (+24.87%) 05/26/23 What You Missed On Wall Street On Friday 05/26/23 What You Missed On Wall Street This Morning 05/26/23 Fly Intel: Pre-market Movers 04/21/23 What You Missed On Wall Street On Friday 06/14/23 June Small-Cap Virtual Conference 09/19/23 Institutional Investor Conference 2023 06/06/23 CarGurus, Inc. 06/07/23 UFP Technologies, Inc. 06/08/23 Moelis & Company 06/15/23 Schrodinger, Inc. 06/21/23 LendingTree, Inc. UFPT BIG UFPT UFP Technologies $159.61 / +1.61 (+1.02%) 02/24/23 Four new option listings and one option delisting on February 24th BIG Big Lots $6.08 / +1.21 (+24.87%) 05/26/23 Largest borrow rate increases among liquid names 05/24/23 Largest borrow rate increases among liquid names 04/19/23 Big Lots call volume above normal and directionally bullish 04/18/23 Big Lots put volume heavy and directionally bearish
Syndicate	MamaMancini's files to sell 7.22M common shares for holders 17:32 06/02/23 06/02 17:32 06/02/23 17:32 MMMB MamaMancini’s $2.53 / + (+0.00%) ShowHide Related Items >><< Company News Street Research MMMB MamaMancini’s $2.53 / + (+0.00%) 06/01/23 MamaMancini's appoints Lauren Sella as CMO 05/31/23 MamaMancini's to launch Mama's Creations deli foods platform brand 04/11/23 MamaMancini's appoints Joselina Peralta as CPO 03/09/23 MamaMancini's appoints Romig to board of directors MMMB MamaMancini’s $2.53 / + (+0.00%) 02/07/23 Lake Street MamaMancinis initiated with a Buy at Lake Street

Hot Stocks	S&P DJI announces changes to S&P400 at open on 6/20 » 17:31 06/02/23 06/02 17:31 06/02/23 17:31 DOCS Doximity $33.03 / +1.47 (+4.66%) , BERY Berry Global $59.94 / +2.12 (+3.67%) , BWXT BWX Technologies $62.99 / +1.63 (+2.66%) , PLNT Planet Fitness $63.73 / +0.61 (+0.97%) , CCK Crown Holdings $80.43 / +3.14 (+4.06%) , DBX Dropbox $23.67 / +0.48 (+2.07%) , GPK Graphic Packaging $25.00 / +0.84 (+3.48%) , OVV Ovintiv $35.59 / +1.5 (+4.40%) , ZI ZoomInfo $26.44 / +0.505 (+1.95%) , WCC Wesco $146.20 / +9.93 (+7.29%) , DAN Dana $13.87 / +0.965 (+7.48%) , WLY Wiley $38.22 / +1.225 (+3.31%) , SPWR SunPower $10.89 / -0.03 (-0.27%) , NGVT Ingevity $51.81 / +4.335 (+9.13%) , FULT Fulton Financial $12.22 / +0.66 (+5.71%) , DEI Douglas Emmett $11.91 / +0.615 (+5.44%) , VSCO Victoria's Secret $20.14 / +1.495 (+8.02%) , MAC Macerich $10.16 / +0.665 (+7.01%) , SITM SiTime $101.89 / -1.31 (-1.27%) , NAVI Navient $16.24 / +0.63 (+4.04%) , PETS PetMed Express $15.95 / +0.44 (+2.84%) , CMTL Comtech $12.34 / +0.21 (+1.73%) , EGRX Eagle Pharmaceuticals $21.56 / +0.79 (+3.80%) , PLCE Children's Place $15.76 / +1.32 (+9.14%) , RYAM Rayonier Advanced Materials $3.75 / +0.25 (+7.15%) , LPSN LivePerson $3.76 / +0.165 (+4.60%) , GCI Gannett $2.25 / +0.06 (+2.74%) , BOOM DMC Global $18.15 / +1.2 (+7.08%) , GCO Genesco $18.90 / +1.05 (+5.88%) , ZUMZ Zumiez $15.47 / -0.2 (-1.28%) Doximity (DOCS), Berry… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 17:31 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ZUMZ ZI WCC VSCO SPWR RYAM PLNT PLCE PETS OVV NAVI MAC LPSN GPK GCO GCI FULT EGRX DOCS DEI DBX DAN CMTL CCK BWXT BOOM BERY ZUMZ Zumiez $15.47 / -0.2 (-1.28%) 06/01/23 Zumiez reports May sales down 12.8%. 04/18/23 Zumiez exec Brown sells 40,000 common shares 03/09/23 Zumiez falls over 11% after guidance misses estimates 03/02/23 OneWater Marine appoints Bauza to board of directors ZI ZoomInfo $26.44 / +0.505 (+1.95%) 03/14/23 ZoomInfo announces $100M share repurchase program 02/01/23 ZoomInfo appoints Ali Dasdan as CTO, Dave Justice as chief revenue officer WCC Wesco $146.20 / +9.93 (+7.29%) 05/04/23 Wesco reports preliminary workday adjusted April sales up 6% y/y 03/03/23 Wesco declares inaugural quarterly cash dividend of 37.5c per share VSCO Victoria's Secret $20.14 / +1.495 (+8.02%) 05/15/23 Greenlight Capital exits positions in Victoria's Secret, Funko 02/24/23 Victoria's Secret, PINK announce pilot of loyalty program 02/21/23 Victoria's Secret, Naomi Osaka launch first design collaboration 02/14/23 Greenlight buys Tenet, exits Intel in Q4 SPWR SunPower $10.89 / -0.03 (-0.27%) 05/15/23 SunPower appoints Elizabeth Eby as CFO 05/08/23 Shoals Technologies spikes higher after results, backlog-awarded orders up 75% 05/01/23 SunPower names Jennifer Johnston as new COO 04/13/23 SunPower announces financing commitments of over $450M for loan program RYAM Rayonier Advanced Materials $3.75 / +0.25 (+7.15%) 05/10/23 Rayonier Advanced Materials falls -18.8% 05/10/23 Rayonier Advanced Materials falls -19.8% 02/28/23 Rayonier Advanced Materials rises 15.7% 01/20/23 Rayonier Advanced Materials falls -10.8% PLNT Planet Fitness $63.73 / +0.61 (+0.97%) 05/15/23 Planet Fitness announces start of its High School Summer Pass program 05/01/23 Planet Fitness announces return of its High School Summer Pass program 03/16/23 Planet Fitness signs technology agreement extension with ABC Fitness Solutions 01/09/23 Planet Fitness reports about 17M members as of December 31, 2022 PLCE Children's Place $15.76 / +1.32 (+9.14%) 05/24/23 Children's Place plans to close 80-100 stores in 2023 05/10/23 Children's Place announces election of all director candidates 02/06/23 Children's Place falls 10% to $42.08 after lowering Q4 outlook PETS PetMed Express $15.95 / +0.44 (+2.84%) 04/03/23 PetMed Express completes acquisition of PetCareRx 02/06/23 PetMed Express announces quarterly dividend of 30c per share 01/17/23 PetMed Express to acquire PetCareRx, terms undisclosed OVV Ovintiv $35.59 / +1.5 (+4.40%) 05/15/23 Third Point buys Alibaba, cuts AIG in Q1 05/09/23 Ovintiv sees FY24 CapEx $2.1B-$2.5B 05/09/23 Ovintiv sees FY23 total production 520-545 MBOE/d 05/09/23 Ovintiv sees FY23 CapEx $2.6B-$2.9B NAVI Navient $16.24 / +0.63 (+4.04%) 05/15/23 Navient names Yowan as President, CEO 02/21/23 Navient named David Green as executive vice president of consumer lending MAC Macerich $10.16 / +0.665 (+7.01%) 01/17/23 Macerich announces Santa Monica Place as site for ARTE MUSEUM LPSN LivePerson $3.76 / +0.165 (+4.60%) 05/15/23 Starboard takes stake in Rogers Corp, boosts stake in Splunk 05/05/23 Starboard expresses serious concerns about LivePerson's stock price 03/23/23 LivePerson divests Kasamba 12/27/22 LivePerson names three new directors as part of prior deal with Starboard GPK Graphic Packaging $25.00 / +0.84 (+3.48%) 02/20/23 Graphic Packaging declares quarterly dividend of 10c 02/07/23 Graphic Packaging on track to meet Vision 2025 financial goals GCO Genesco $18.90 / +1.05 (+5.88%) 05/25/23 Genesco falls -32.5% 05/25/23 Genesco falls -25.0% 03/09/23 Genesco falls -12.0% 01/09/23 Genesco reports quarter-to-date comparable sales increased 3% GCI Gannett $2.25 / +0.06 (+2.74%) 03/08/23 Gambling.com ready to launch online sports betting in MA with BetMassachusetts 03/06/23 Gannett appoints Kristin Roberts as CCO 02/23/23 Gannett rises 18.6% 02/08/23 Gannett sees strategic partnership with Gambling.com as immediately accretive FULT Fulton Financial $12.22 / +0.66 (+5.71%) 04/18/23 Fulton Financial slips 4% to $12.60 after Q1 earnings miss 12/20/22 Fulton Financial announces up to $100M share buyback EGRX Eagle Pharmaceuticals $21.56 / +0.79 (+3.80%) 05/01/23 Eagle Pharmaceuticals granted unique J-code for Byfavo from the CMS 04/05/23 Eagle announces settlement agreement with Dr. Reddy's 12/19/22 Eagle Pharmaceuticals: FDA approves additional indication for PEMFEXY combo 12/12/22 Eagle Pharmaceuticals reaches settlement agreement with Accord DOCS Doximity $33.03 / +1.47 (+4.66%) 05/17/23 Doximity falls -8.1% 05/16/23 Doximity announces new integration with MEDITECH 05/16/23 Doximity down 3% at $32.89 after Q4 results, FY24 guidance 03/28/23 Doximity falls -6.3% DEI Douglas Emmett $11.91 / +0.615 (+5.44%) 12/08/22 Douglas Emmett cuts quarterly cash dividend to 19c per share from 28c 12/08/22 Douglas Emmett announces $300M share repurchase authorization DBX Dropbox $23.67 / +0.48 (+2.07%) 05/04/23 Dropbox maintains long-term targets of 80%-82% in gross margins 04/27/23 Dropbox to reduce global workforce by 16% 02/16/23 Dropbox says FY23 guidance does not assume turn around in economy 02/16/23 Dropbox does not expect to enter sub-leases in San Fran area in next few years DAN Dana $13.87 / +0.965 (+7.48%) 03/06/23 Dana plans to achieve net zero by 2040 02/21/23 Dana falls -13.8% 02/21/23 Dana falls -11.2% 02/21/23 Dana falls -11.7% CMTL Comtech $12.34 / +0.21 (+1.73%) 04/18/23 Comtech names Nicole Robinson chief strategy officer 04/17/23 Comtech secures contracts for hybrid designed high-speed SATCOM solutions 04/12/23 Comtech names Donald Walther as CLO 03/16/23 Comtech awarded $29M for communications technologies and location services CCK Crown Holdings $80.43 / +3.14 (+4.06%) 04/24/23 Crown Holdings jumps 13% to $89.25 after Q1 EPS beat estimates 02/14/23 Icahn boosts stake in Crown Holdings, reduces stake in Cheniere Energy 12/13/22 Crown Holdings appoints two new directors to Board from Icahn Enterprises BWXT BWX Technologies $62.99 / +1.63 (+2.66%) 05/01/23 Proterra announces appointment of David Black as CFO 04/17/23 BWX-led team awarded $45B contract for DOE's Hanford site 04/13/23 BWX, Fluor in group awarded DOE contract worth up to $45B 03/21/23 BWX Technologies awarded engineering contract from GE Hitachi Nuclear Energy BOOM DMC Global $18.15 / +1.2 (+7.08%) 04/05/23 DMC Global announces DynaEnergetics defense of patent infringement case 01/20/23 DMC Global appoints Eric Walter as CFO 01/17/23 DMC Global CEO Kevin Longe steps down immediately Michael Kuta succeeds BERY Berry Global $59.94 / +2.12 (+3.67%) 02/20/23 Fly Intel: Top five weekend stock stories 02/02/23 Berry Global CEO Thomas Salmon to retire DOCS BERY BWXT PLNT CCK DBX GPK OVV ZI WCC DAN WLY SPWR NGVT FULT DEI VSCO MAC SITM NAVI PETS CMTL EGRX PLCE RYAM LPSN GCI BOOM GCO ZUMZ DOCS Doximity $33.03 / +1.47 (+4.66%) 05/17/23 Evercore ISI Doximity price target lowered to $32 from $33 at Evercore ISI 05/17/23 Canaccord Doximity price target lowered to $40 from $41 at Canaccord 05/01/23 Wells Fargo Doximity downgraded to Equal Weight on slowing ad growth at Wells Fargo 05/01/23 Wells Fargo Doximity downgraded to Equal Weight from Overweight at Wells Fargo BERY Berry Global $59.94 / +2.12 (+3.67%) 05/24/23 Truist Berry Global upgraded to Buy at Truist on increased urgency regarding costs 05/24/23 Truist Berry Global upgraded to Buy from Hold at Truist 05/08/23 UBS Berry Global price target lowered to $73 from $75 at UBS 05/05/23 Mizuho Berry Global price target raised to $65 from $64 at Mizuho BWXT BWX Technologies $62.99 / +1.63 (+2.66%) 05/14/23 Barclays BWX Technologies price target raised to $70 from $64 at Barclays 12/08/22 Barclays BWX Technologies upgraded to Equal Weight from Underweight at Barclays 11/29/22 Maxim BWX Technologies price target raised to $70 from $65 at Maxim 10/11/22 Credit Suisse Credit Suisse starts BWX at Outperform on 'exceptional' free cash outlook PLNT Planet Fitness $63.73 / +0.61 (+0.97%) 05/19/23 RBC Capital Planet Fitness initiated with an Outperform at RBC Capital 05/08/23 DA Davidson Planet Fitness price target lowered to $67 from $87 at DA Davidson 05/05/23 BMO Capital Planet Fitness price target lowered to $82 from $90 at BMO Capital 05/05/23 TD Cowen Planet Fitness price target lowered to $80 from $92 at TD Cowen CCK Crown Holdings $80.43 / +3.14 (+4.06%) 04/27/23 Citi Crown Holdings price target raised to $104 from $103 at Citi 04/26/23 Mizuho Crown Holdings price target raised to $108 from $103 at Mizuho 03/27/23 Wells Fargo Crown Holdings price target lowered to $79 from $86 at Wells Fargo 02/13/23 Barclays Crown Holdings price target raised to $95 from $90 at Barclays DBX Dropbox $23.67 / +0.48 (+2.07%) 05/23/23 Jefferies Alphabet price target raised to $150 from $130 at Jefferies 05/15/23 Gordon Haskett Gordon Haskett wonders if UBS was 'putting Elliott into' Dropbox along with GT 05/12/23 Gordon Haskett UBS position in Dropbox 'maybe' for activist, says Gordon Haskett 05/08/23 Goldman Sachs Dropbox upgraded to Neutral from Sell at Goldman Sachs GPK Graphic Packaging $25.00 / +0.84 (+3.48%) 05/03/23 Deutsche Bank Graphic Packaging price target raised to $30 from $28 at Deutsche Bank 05/03/23 Raymond James Graphic Packaging price target raised to $30 from $29 at Raymond James 05/03/23 Mizuho Graphic Packaging price target raised to $31 from $30 at Mizuho 02/09/23 RBC Capital Graphic Packaging price target raised to $35 from $31 at RBC Capital OVV Ovintiv $35.59 / +1.5 (+4.40%) 05/23/23 CIBC Ovintiv price target lowered to $50 from $55 at CIBC 05/19/23 Mizuho Ovintiv price target lowered to $62 from $66 at Mizuho 05/12/23 Wells Fargo Ovintiv price target lowered to $36 from $40 at Wells Fargo 04/18/23 UBS Ovintiv assumed with a Buy at UBS ZI ZoomInfo $26.44 / +0.505 (+1.95%) 05/18/23 DA Davidson ZoomInfo price target raised to $40 from $30 at DA Davidson 05/16/23 Gordon Haskett ZoomInfo ramp at Morgan Stanley 'could be something,' says Gordon Haskett 05/04/23 DA Davidson ZoomInfo initiated with a Buy at DA Davidson 05/03/23 DA Davidson ZoomInfo initiated with a Buy at DA Davidson WCC Wesco $146.20 / +9.93 (+7.29%) 05/26/23 Oppenheimer Wesco price target raised to $190 from $180 at Oppenheimer 05/05/23 Baird Wesco upgraded to Outperform from Neutral at Baird 02/15/23 RBC Capital Wesco price target raised to $200 from $163 at RBC Capital 02/15/23 Oppenheimer Wesco price target raised to $200 from $175 at Oppenheimer DAN Dana $13.87 / +0.965 (+7.48%) 05/01/23 Deutsche Bank Dana price target raised to $16 from $15 at Deutsche Bank 04/17/23 Barclays Dana price target lowered to $17 from $18 at Barclays 02/22/23 Deutsche Bank Dana price target lowered to $14 from $16 at Deutsche Bank 02/22/23 Barclays Dana price target lowered to $18 from $20 at Barclays WLY Wiley $38.22 / +1.225 (+3.31%) 09/08/22 CJS Securities Wiley upgraded to Outperform from Market Perform at CJS Securities 08/29/22 CJS Securities Wiley downgraded to Market Perform from Outperform at CJS Securities SPWR SunPower $10.89 / -0.03 (-0.27%) 05/12/23 Piper Sandler Treasury IRA guidance improves First Solar competitive position, says Piper 05/12/23 Roth MKM Domestic content ITC adder 'substantial positive' for First Solar, says Roth 05/12/23 BofA SunPower price target lowered to $13 from $15 at BofA 05/09/23 Piper Sandler SunPower price target lowered to $12 from $15 at Piper Sandler NGVT Ingevity $51.81 / +4.335 (+9.13%) 05/23/23 Wells Fargo Ingevity price target lowered to $55 from $66 at Wells Fargo 05/09/23 BMO Capital Ingevity price target lowered to $80 from $100 at BMO Capital 05/05/23 Loop Capital Ingevity cut to Hold at Loop Capital amid structural changes in pine chemicals 05/05/23 Loop Capital Ingevity downgraded to Hold from Buy at Loop Capital FULT Fulton Financial $12.22 / +0.66 (+5.71%) 04/20/23 DA Davidson Fulton Financial price target lowered to $14 from $15 at DA Davidson 04/20/23 Piper Sandler Fulton Financial price target lowered to $14 from $15 at Piper Sandler 01/19/23 DA Davidson Fulton Financial price target lowered to $17 from $18 at DA Davidson 01/10/23 Janney Montgomery Scott Fulton Financial initiated with a Neutral at Janney Montgomery Scott DEI Douglas Emmett $11.91 / +0.615 (+5.44%) 04/05/23 Piper Sandler Douglas Emmett upgraded to Overweight from Neutral at Piper Sandler 03/30/23 BMO Capital Douglas Emmett price target lowered to $12 from $14 at BMO Capital 03/29/23 BMO Capital Douglas Emmett price target lowered to $12 from $13 at BMO Capital 03/27/23 Evercore ISI Douglas Emmett price target lowered to $16 from $17 at Evercore ISI VSCO Victoria's Secret $20.14 / +1.495 (+8.02%) 06/02/23 TD Cowen Victoria's Secret price target lowered to $21 from $45 at TD Cowen 06/02/23 Morgan Stanley Victoria's Secret price target lowered to $19 from $44 at Morgan Stanley 06/02/23 Wells Fargo Victoria's Secret price target lowered to $34 from $55 at Wells Fargo 06/02/23 Barclays Victoria's Secret price target lowered to $21 from $35 at Barclays MAC Macerich $10.16 / +0.665 (+7.01%) 05/26/23 Mizuho Macerich price target lowered to $9 from $11 at Mizuho 05/05/23 Piper Sandler Macerich price target lowered to $9 from $11 at Piper Sandler 03/21/23 Goldman Sachs Macerich resumed with a Sell at Goldman Sachs 12/16/22 Truist Macerich price target raised to $15 from $13 at Truist SITM SiTime $101.89 / -1.31 (-1.27%) 05/05/23 Barclays SiTime downgraded to Equal Weight from Overweight at Barclays 05/04/23 Stifel SiTime price target lowered to $126 from $140 at Stifel 05/04/23 Needham Needham cuts SiTime to Hold on low visibility into consumption run-rate 05/04/23 Needham SiTime downgraded to Hold from Buy at Needham NAVI Navient $16.24 / +0.63 (+4.04%) 04/18/23 Citi Navient price target lowered to $17 from $19 at Citi 04/17/23 JPMorgan Navient price target lowered to $16 from $18 at JPMorgan 01/26/23 Stephens Navient price target raised to $20 from $17 at Stephens 01/26/23 BMO Capital Navient price target raised to $19 from $17 at BMO Capital PETS PetMed Express $15.95 / +0.44 (+2.84%) 05/25/23 Lake Street Lake Street starts PetMed Express with a Buy, $20 price target 05/25/23 Lake Street PetMed Express initiated with a Buy at Lake Street 03/23/23 Morgan Stanley PetMed Express price target lowered to $17 from $18 at Morgan Stanley 09/21/22 Jefferies PetMed Express transferred with a Hold at Jefferies CMTL Comtech $12.34 / +0.21 (+1.73%) 10/04/22 Northland Comtech cloud messaging customer likely AT&T or T-Mobile, says Northland 06/15/22 Jefferies Comtech downgraded to Hold from Buy at Jefferies 06/13/22 Noble Capital Comtech upgraded to Outperform from Market Perform at Noble Capital 06/10/22 Citi Comtech price target lowered to $14 from $20 at Citi EGRX Eagle Pharmaceuticals $21.56 / +0.79 (+3.80%) 05/10/23 Piper Sandler Eagle Pharmaceuticals price target lowered to $26 from $31 at Piper Sandler 03/14/23 Piper Sandler Eagle Pharmaceuticals price target lowered to $31 from $41 at Piper Sandler PLCE Children's Place $15.76 / +1.32 (+9.14%) 05/25/23 UBS Children's Place price target lowered to $20 from $40 at UBS 05/11/23 B. Riley Children's Place initiated with a Buy at B. Riley 03/29/23 UBS Children's Place price target lowered to $40 from $45 at UBS 02/07/23 Telsey Advisory Children's Place downgraded to Market Perform from Outperform at Telsey RYAM Rayonier Advanced Materials $3.75 / +0.25 (+7.15%) 05/11/23 RBC Capital Rayonier Advanced upgraded to Outperform from Sector Perform at RBC Capital 01/09/23 RBC Capital Rayonier Advanced Materials cut to Sector Perform at RBC Capital on valuation 01/09/23 RBC Capital Rayonier Advanced downgraded to Sector Perform from Outperform at RBC Capital 10/13/22 BofA Rayonier Advanced Materials price target lowered to $1.90 from $2.60 at BofA LPSN LivePerson $3.76 / +0.165 (+4.60%) 05/11/23 Mizuho LivePerson price target lowered to $6 from $7 at Mizuho 05/08/23 Loop Capital Loop Capital cuts LivePerson to Sell, sees Starboard matter as major distraction 05/08/23 Loop Capital LivePerson downgraded to Sell from Hold at Loop Capital 03/17/23 Credit Suisse LivePerson upgraded to Neutral from Underperform at Credit Suisse GCI Gannett $2.25 / +0.06 (+2.74%) 11/17/22 Citi Gannett price target raised to $2.10 from $1.70 at Citi 08/25/22 Citi Gannett price target lowered to $1.70 from $2.65 at Citi 07/07/22 Citi Gannett price target lowered to $2.65 from $4.25 at Citi BOOM DMC Global $18.15 / +1.2 (+7.08%) 02/27/23 Roth MKM DMC Global price target raised to $35 from $30 at Roth MKM 09/14/22 DMC Global management to meet with Roth Capital GCO Genesco $18.90 / +1.05 (+5.88%) 03/28/23 Seaport Research Seaport upgrades Genesco to Buy into improved performance 03/28/23 Seaport Research Genesco upgraded to Buy from Neutral at Seaport Research 08/30/22 Genesco downgraded to Neutral from Buy at Seaport Global 08/30/22 Genesco downgraded to Neutral from Buy at Seaport Global ZUMZ Zumiez $15.47 / -0.2 (-1.28%) 03/22/23 B. Riley Zumiez price target lowered to $21 from $25 at B. Riley 09/09/22 B. Riley Zumiez downgraded to Neutral after 'substantial' miss at B. Riley 09/09/22 William Blair William Blair downgrades Zumiez on 'sluggish' sales trends 09/09/22 William Blair Zumiez downgraded to Market Perform from Outperform at William Blair ZUMZ ZI WLY WCC VSCO SPWR SITM RYAM PLNT PLCE PETS OVV NGVT NAVI MAC LPSN GPK GCO FULT EGRX DOCS DEI DBX DAN CMTL CCK BWXT BOOM BERY ZUMZ Zumiez $15.47 / -0.2 (-1.28%) 06/01/23 Zumiez sees Q2 EPS (73c)-(63c), consensus (35c) 06/01/23 Zumiez reports Q1 EPS (96c), consensus (86c) 03/09/23 Zumiez sees Q1 EPS (85c)-(95c) , one estimate 3c 03/09/23 Zumiez sees Q1 EPS (85c)-(95c), consensus 3c ZI ZoomInfo $26.44 / +0.505 (+1.95%) 05/01/23 ZoomInfo sees FY23 adjusted EPS 99c-$1.01 vs. prior 98c-$1.00 05/01/23 ZoomInfo sees Q2 adjusted EPS 22c-23c, consensus 23c 05/01/23 ZoomInfo reports Q1 EPS 24c, consensus 22c 05/01/23 Notable companies reporting after market close WLY Wiley $38.22 / +1.225 (+3.31%) 03/09/23 Wiley cuts FY23 adjusted EPS view to $3.30-$3.55 from $3.70-$4.05 03/09/23 Wiley reports Q3 adjusted EPS 85c vs. 95c last year WCC Wesco $146.20 / +9.93 (+7.29%) 05/04/23 Wesco reaffirms FY23 adjusted EPS view $16.80-$18.30, consensus $17.51 05/04/23 Wesco reports Q1 adjusted EPS $3.75, consensus $3.57 02/14/23 Wesco sees FY23 adjusted EPS $16.80-$18.30, consensus $16.51 02/14/23 Wesco reports Q4 adjusted EPS $4.13, consensus $3.79 VSCO Victoria's Secret $20.14 / +1.495 (+8.02%) 05/31/23 Victoria's Secret cuts FY23 revenue view to flat to down low single digits 05/31/23 Victoria's Secret sees Q2 EPS 10c-40c, consensus 88c 05/31/23 Victoria's Secret sees Q1 EPS 10c-40c, consensus 88c 05/31/23 Victoria's Secret reports Q1 adjusted EPS 28c, consensus 54c SPWR SunPower $10.89 / -0.03 (-0.27%) 05/03/23 SunPower reaffirms FY23 adjusted EBITDA view $125M-$155M 05/03/23 SunPower reports Q1 non-GAAP EPS (7c), consensus (1c) 02/15/23 SunPower reports Q4 adjusted EPS 15c, consensus 13c 02/15/23 Notable companies reporting after market close SITM SiTime $101.89 / -1.31 (-1.27%) 05/04/23 SiTime reports Q1 EPS 9c, consensus 0c 02/02/23 SiTime reports Q4 EPS 64c, consensus 55c RYAM Rayonier Advanced Materials $3.75 / +0.25 (+7.15%) 05/09/23 Rayonier Advanced affirms 2023 adjusted free cash flow outlook $200M-$215M 05/09/23 Rayonier Advanced Materials reports Q1 EPS 2c, consensus 6c 01/17/23 Rayonier Advanced Materials sees Q4 revenue $488M-$508M PLNT Planet Fitness $63.73 / +0.61 (+0.97%) 05/04/23 Planet Fitness backs FY23 adjusted EPS view up 33%-36%, consensus $2.21 05/04/23 Planet Fitness reports Q1 adjusted EPS 41c, consensus 46c 02/23/23 Planet Fitness sees FY23 adjusted EPS up 33%-36%, consensus $2.06 02/23/23 Planet Fitness reports Q4 adjusted EPS 53c, consensus 47c PLCE Children's Place $15.76 / +1.32 (+9.14%) 05/24/23 Children's Place sees 2023 adjusted EPS $1.00-$1.50, consensus $2.15 05/24/23 Children's Place sees Q2 adjusted EPS ($2.15)-($2.20), consensus ($1.56) 05/24/23 Children's Place reports Q1 adjusted EPS ($2.00), consensus ($1.83) 03/16/23 Children's Place sees FY23 adjusted EPS $2.50-$3.00, consensus $3.35 PETS PetMed Express $15.95 / +0.44 (+2.84%) 05/22/23 PetMed Express reports Q4 EPS (25c), consensus 14c 05/22/23 PetMed Express reports Q4 adjusted EPS 29c, consensus 14c 02/06/23 PetMed Express reports Q3 EPS 21c, consensus 20c OVV Ovintiv $35.59 / +1.5 (+4.40%) 05/09/23 Ovintiv reports Q1 EPS $1.97, consensus $1.83 02/27/23 Ovintiv reports Q4 EPS $5.30, consensus $1.87 NGVT Ingevity $51.81 / +4.335 (+9.13%) 05/03/23 Ingevity sees FY23 revenue $1.75B-$1.95B, consensus $1.92B 05/03/23 Ingevity reports Q1 adjusted EPS $1.35, consensus $1.13 02/27/23 Ingevity sees FY23 revenue $1.9B-$2.1B, consensus $1.83B 02/27/23 Ingevity reports Q4 adjusted EPS 57c, consensus 87c NAVI Navient $16.24 / +0.63 (+4.04%) 04/26/23 Navient sees FY23 adjusted core EPS $3.15-$3.30, consensus $3.19 04/26/23 Navient reports Q1 adjusted EPS $1.06, consensus 82c 01/24/23 Navient sees FY23 core EPS $3.15-$3.30, consensus $2.92 01/24/23 Navient reports Q4 adjusted EPS 85c, consensus 83c MAC Macerich $10.16 / +0.665 (+7.01%) 02/07/23 Macerich sees FY23 FFO $1.75-$1.85, consensus $1.84 02/07/23 Macerich reports Q4 FFO 53c, consensus 52c LPSN LivePerson $3.76 / +0.165 (+4.60%) 05/09/23 LivePerson sees Q2 revenue $95M-$99M, consensus $99.71M 05/09/23 LivePerson reaffirms FY23 revenue view $394M-$408M, consensus $410.24M 05/09/23 LivePerson reports Q1 EPS (23c), consensus (49c) 03/15/23 LivePerson sees FY23 revenue $395M-$410M, consensus $551.48M GPK Graphic Packaging $25.00 / +0.84 (+3.48%) 05/02/23 Graphic Packaging raises FY23 adjusted EPS view to $2.70-$3.10 from $2.50-$2.90 05/02/23 Graphic Packaging reports Q1 adjusted EPS 77c, consensus 62c 02/07/23 Graphic Packaging sees FY23 adjusted EPS $2.50-$2.90, consensus $2.55 02/07/23 Graphic Packaging reports Q4 adjusted EPS 59c, consensus 58c GCO Genesco $18.90 / +1.05 (+5.88%) 05/25/23 Genesco sees FY24 adjusted EPS $2.00-$2.50, two estimates $5.39 05/25/23 Genesco reports Q1 EPS ($1.59) vs. 44c last year 03/09/23 Genesco sees FY24 adjusted EPS $5.10-$5.90, consensus $6.83 03/09/23 Genesco reports Q4 EPS $3.06, consensus $3.02 FULT Fulton Financial $12.22 / +0.66 (+5.71%) 04/19/23 Fulton Financial sees FY23 NII $850M-$870M vs. previous view of $895M-$915M 04/18/23 Fulton Financial reports Q1 EPS 39c, consensus 48c 01/18/23 Fulton Financial sees FY23 NII $895M-$915M 01/17/23 Fulton Financial reports Q4 adjusted EPS 48c, consensus 50c EGRX Eagle Pharmaceuticals $21.56 / +0.79 (+3.80%) 05/09/23 Eagle Pharmaceuticals backs FY23 adjusted EPS view $4.20-$4.53, consensus $4.21 05/09/23 Eagle Pharmaceuticals reports Q1 adjusted EPS $1.26, consensus $1.05 03/13/23 Eagle Pharmaceuticals sees 2023 adjusted EPS $4.20-$4.53, consensus $4.49 03/13/23 Eagle Pharmaceuticals reports Q4 adjusted EPS $1.10, consensus 83c DOCS Doximity $33.03 / +1.47 (+4.66%) 05/16/23 Doximity sees FY24 revenue $500M-$506M, consensus $507.1M 05/16/23 Doximity sees Q1 revenue $106.5M-$107.5M, consensus $112.1M 05/16/23 Doximity reports Q4 EPS 20c, consensus 17c 02/09/23 Doximity guides initial FY24 revenue of 'greater than' $500M, consensus $519.4M DEI Douglas Emmett $11.91 / +0.615 (+5.44%) 05/02/23 Douglas Emmett backs FY23 FFO view $1.87-$1.93, consensus $1.91 05/02/23 Douglas Emmett reports Q1 FFO 47c, consensus 48c 02/07/23 Douglas Emmett sees FY23 FFO $1.87-$1.93, consensus $1.97 02/07/23 Douglas Emmett reports Q4 FFO 51c, consensus 52c DBX Dropbox $23.67 / +0.48 (+2.07%) 05/04/23 Dropbox reports Q1 EPS 42c, consensus 36c 05/04/23 Notable companies reporting after market close 02/16/23 Dropbox sees FY23 revenue $2.475B-$2.49B, consensus $2.44B 02/16/23 Dropbox sees Q1 revenue $600M-$603M, consensus $590.03M DAN Dana $13.87 / +0.965 (+7.48%) 04/28/23 Dana reports Q1 adjusted EPS 25c, consensus $1.04 02/21/23 Dana sees FY23 adjusted EPS 25c-75c, consensus $1.73 02/21/23 Dana reports Q4 EPS (10c), consensus 26c CMTL Comtech $12.34 / +0.21 (+1.73%) 03/09/23 Comtech sees Q3 revenue up 1% to 3% from Q2 03/09/23 Comtech reports Q2 EPS (23c), consensus (9c) 12/08/22 Comtech sees Q2 revenue growth 1%-3% sequentially, consensus $128.1M 12/08/22 Comtech reports Q1 EPS (46c), consensus (10c) CCK Crown Holdings $80.43 / +3.14 (+4.06%) 04/24/23 Crown Holdings backs FY23 adjusted EPS view $6.20-$6.40, consensus $6.28 04/24/23 Crown Holdings sees Q2 adjusted EPS $1.60-$1.70, consensus $1.76 04/24/23 Crown Holdings reports Q1 adjusted EPS $1.20, consensus $1.05 04/24/23 Notable companies reporting after market close BWXT BWX Technologies $62.99 / +1.63 (+2.66%) 05/08/23 BWX Technologies backs FY23 EPS view $2.80-$3.00, consensus $2.88 05/08/23 BWX Technologies reports Q1 adjusted EPS 70c, consensus 61c 02/23/23 BWX Technologies sees FY23 adjusted EPS $2.80-$3.00, consensus $2.88 02/23/23 BWX Technologies reports Q4 adjusted EPS 93c, consensus 93c BOOM DMC Global $18.15 / +1.2 (+7.08%) 05/05/23 DMC Global sees Q2 revenue $177M-$187M, consensus $177.37M 05/05/23 DMC Global reports Q1 adjusted EPS 32c, consensus 30c 02/23/23 DMC Global sees Q1 revenue $$168M-$178M, consensus $164.43M 02/23/23 DMC Global reports Q4 EPS 22c, consensus 29c BERY Berry Global $59.94 / +2.12 (+3.67%) 05/04/23 Berry Global reports Q1 EPS $1.96, consensus $1.86 02/02/23 Berry Global reports Q1 EPS $1.30, consensus $1.28 PLNT OVV BERY PLNT Planet Fitness $63.73 / +0.61 (+0.97%) 01/19/23 Planet Fitness received 'hundreds' of consumer complaints, says The Bear Cave OVV Ovintiv $35.59 / +1.5 (+4.40%) 04/06/23 Buyout firm EnCap ponders nearly $3B of Permian asset sales, Reuters reports BERY Berry Global $59.94 / +2.12 (+3.67%) 02/18/23 Dow, Celanese among stocks to play future of plastic, Barron's says ZUMZ ZI VSCO SPWR RYAM PLNT PLCE PETS OVV NGVT NAVI LPSN GCO FULT DOCS DEI DBX DAN CMTL CCK BWXT ZUMZ Zumiez $15.47 / -0.2 (-1.28%) 06/01/23 Fly Intel: After-Hours Movers 03/10/23 Fly Intel: Pre-market Movers 03/09/23 Fly Intel: After-Hours Movers ZI ZoomInfo $26.44 / +0.505 (+1.95%) 05/04/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/01/23 Fly Intel: After-Hours Movers 02/07/23 What You Missed On Wall Street On Tuesday 02/07/23 What You Missed On Wall Street This Morning VSCO Victoria's Secret $20.14 / +1.495 (+8.02%) 06/01/23 What You Missed On Wall Street On Thursday 06/01/23 What You Missed On Wall Street This Morning 06/01/23 Fly Intel: Pre-market Movers 05/31/23 Fly Intel: After-Hours Movers SPWR SunPower $10.89 / -0.03 (-0.27%) 04/17/23 What You Missed This Week in EVs and Clean Energy 04/13/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/03/23 What You Missed This Week in EVs and Clean Energy 03/30/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations RYAM Rayonier Advanced Materials $3.75 / +0.25 (+7.15%) 01/10/23 What You Missed On Wall Street On Tuesday 01/10/23 What You Missed On Wall Street This Morning PLNT Planet Fitness $63.73 / +0.61 (+0.97%) 05/05/23 What You Missed On Wall Street On Friday 05/05/23 What You Missed On Wall Street This Morning 02/23/23 Fly Intel: Pre-market Movers 02/16/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations PLCE Children's Place $15.76 / +1.32 (+9.14%) 05/24/23 What You Missed On Wall Street On Wednesday 05/24/23 What You Missed On Wall Street This Morning 05/24/23 Fly Intel: Pre-market Movers 03/16/23 What You Missed On Wall Street On Thursday PETS PetMed Express $15.95 / +0.44 (+2.84%) 05/25/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/22/23 Fly Intel: After-Hours Movers 04/30/23 Short Report: Bears boost Vivid Seats position to record high as stock bottoms 02/11/23 Short Report: Bearish bets in crypto, EV technology recede amid profit-taking OVV Ovintiv $35.59 / +1.5 (+4.40%) 03/14/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations NGVT Ingevity $51.81 / +4.335 (+9.13%) 05/05/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations NAVI Navient $16.24 / +0.63 (+4.04%) 01/25/23 Fly Intel: Pre-market Movers 01/24/23 Fly Intel: After-Hours Movers LPSN LivePerson $3.76 / +0.165 (+4.60%) 05/08/23 What You Missed On Wall Street On Monday 05/08/23 What You Missed On Wall Street This Morning 05/08/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/17/23 What You Missed On Wall Street On Friday GCO Genesco $18.90 / +1.05 (+5.88%) 03/09/23 Fly Intel: Pre-market Movers FULT Fulton Financial $12.22 / +0.66 (+5.71%) 04/19/23 What You Missed On Wall Street On Wednesday 04/19/23 What You Missed On Wall Street This Morning DOCS Doximity $33.03 / +1.47 (+4.66%) 05/17/23 What You Missed On Wall Street On Wednesday 05/17/23 What You Missed On Wall Street This Morning 05/16/23 Fly Intel: After-Hours Movers 05/01/23 What You Missed On Wall Street On Monday DEI Douglas Emmett $11.91 / +0.615 (+5.44%) 03/03/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations DBX Dropbox $23.67 / +0.48 (+2.07%) 05/04/23 Fly Intel: After-Hours Movers 04/10/23 Fly Insider: Planet Labs, C3.ai among week's notable insider trades 02/17/23 What You Missed On Wall Street On Friday 02/17/23 What You Missed On Wall Street This Morning DAN Dana $13.87 / +0.965 (+7.48%) 02/22/23 Here's what Wall Street experts are saying about these EV names ahead of results 02/21/23 What You Missed On Wall Street On Tuesday 02/21/23 What You Missed On Wall Street This Morning CMTL Comtech $12.34 / +0.21 (+1.73%) 12/09/22 What You Missed On Wall Street On Friday 12/09/22 What You Missed On Wall Street This Morning CCK Crown Holdings $80.43 / +3.14 (+4.06%) 04/24/23 Fly Intel: After-Hours Movers BWXT BWX Technologies $62.99 / +1.63 (+2.66%) 04/17/23 Fly Intel: After-Hours Movers 12/15/23 AI Conference Object & Language Understanding 06/08/23 Comtech - CMTL 06/15/23 Wiley - WLY 06/05/23 Crown Holdings 06/05/23 Ovintiv 06/05/23 Gannett Co Inc. 06/06/23 Ovintiv 06/07/23 Ovintiv 06/08/23 Ovintiv 06/13/23 Genesco 06/20/23 Crown Holdings 06/21/23 Crown Holdings 06/22/23 Genesco Inc. 06/28/23 Eagle Pharmaceuticals, Inc. ZI VSCO SPWR RYAM PETS OVV LPSN DOCS DBX ZI ZoomInfo $26.44 / +0.505 (+1.95%) 05/01/23 ZoomInfo Technologies options imply 8.5% move in share price post-earnings 04/03/23 ZoomInfo Technologies call volume above normal and directionally bullish 02/06/23 ZoomInfo Technologies options imply 12.3% move in share price post-earnings VSCO Victoria's Secret $20.14 / +1.495 (+8.02%) 05/31/23 Victoria's Secret options imply 12.8% move in share price post-earnings 04/05/23 Victoria's Secret call volume above normal and directionally bullish 12/27/22 Victoria's Secret put volume heavy and directionally bearish 12/19/22 Unusually active option classes on open December 19th SPWR SunPower $10.89 / -0.03 (-0.27%) 05/30/23 SunPower call volume above normal and directionally bullish 05/12/23 SunPower call volume above normal and directionally bullish 04/06/23 Unusually active option classes on open April 6th 03/29/23 SunPower call volume above normal and directionally bullish RYAM Rayonier Advanced Materials $3.75 / +0.25 (+7.15%) 05/18/23 Rayonier Advanced Materials put buyer realizes 50% same-day gains 05/17/23 Unusually active option classes on open May 17th 03/23/23 Largest borrow rate increases among liquid names 02/27/23 Rayonier Advanced Materials options imply 16.1% move in share price post-earnings PETS PetMed Express $15.95 / +0.44 (+2.84%) 05/22/23 PetMed Express options imply 6.7% move in share price post-earnings 05/08/23 PetMed Express options imply 6.5% move in share price post-earnings 02/06/23 PetMed Express options imply 9.2% move in share price post-earnings OVV Ovintiv $35.59 / +1.5 (+4.40%) 02/27/23 Ovintiv options imply 3.7% move in share price post-earnings LPSN LivePerson $3.76 / +0.165 (+4.60%) 03/15/23 LivePerson options imply 13.3% move in share price post-earnings DOCS Doximity $33.03 / +1.47 (+4.66%) 05/16/23 Doximity options imply 12.1% move in share price post-earnings 02/09/23 Doximity options imply 11.0% move in share price post-earnings DBX Dropbox $23.67 / +0.48 (+2.07%) 05/15/23 Dropbox call volume above normal and directionally bullish 05/12/23 Unusually active option classes on open May 12th 02/21/23 Dropbox put volume heavy and directionally bearish 02/16/23 Dropbox options imply 4.2% move in share price post-earnings
Syndicate	Eightco Holdings files to sell 13.75M shares of common stock for holders 17:31 06/02/23 06/02 17:31 06/02/23 17:31 OCTO Eightco Holdings $1.77 / -0.03 (-1.67%) ShowHide Related Items >><< Company News OCTO Eightco Holdings $1.77 / -0.03 (-1.67%) 05/31/23 Eightco's Forever 8, Mobi-hub serve as headline sponsor for ITC Malta 2023 05/25/23 Forever 8, Mobi-hub Funding announce strategic partnership 05/17/23 Eightco's Forever 8 signs inventory management agreement with Mobi-hub 05/02/23 Eightco Holdings begins non-deal roadshow
Conference/Events	Jefferies software analyst to hold an analyst/industry conference call » 17:29 06/02/23 06/02 17:29 06/02/23 17:29 SHOP Shopify $58.28 / +0.37 (+0.64%) , BIGC BigCommerce $9.35 / +0.485 (+5.47%) , GLBE Global-e Online $34.73 / -0.16 (-0.46%) Software Analyst Samana,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 17:29 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SHOP GLBE BIGC SHOP Shopify $58.28 / +0.37 (+0.64%) 05/04/23 Shopify rises 27.3% 05/04/23 Shopify rises 22.3% 05/04/23 Shopify rises 19.0% 05/04/23 Shopify says 'will be smaller by about 20%' after today GLBE Global-e Online $34.73 / -0.16 (-0.46%) 01/09/23 Cathie Wood's ARK Investment bought 68.4K shares of Global-e Online today BIGC BigCommerce $9.35 / +0.485 (+5.47%) 05/24/23 BigCommerce appoints Daniel Lentz as CFO, Cassidy as General Counsel 05/09/23 BigCommerce, Oracle partner to help merchants support business growth 02/21/23 WPP and BigCommerce partner to enhance global ecommerce offerings 01/19/23 BigCommerce announces Aadms to join company as SVP, general manager for EMEA SHOP BIGC GLBE SHOP Shopify $58.28 / +0.37 (+0.64%) 05/24/23 Exane BNP Paribas Exane downgrades Shopify to Underperform on small business exposure 05/24/23 Exane BNP Paribas Shopify downgraded to Underperform from Neutral at Exane BNP Paribas 05/23/23 BofA Global-e Online price target raised to $42 from $36 at BofA 05/09/23 Loop Capital Shopify price target raised to $69 from $60 at Loop Capital BIGC BigCommerce $9.35 / +0.485 (+5.47%) 05/08/23 Canaccord BigCommerce price target lowered to $10 from $12 at Canaccord 05/05/23 Morgan Stanley BigCommerce assumed with an Equal Weight at Morgan Stanley 05/05/23 Piper Sandler BigCommerce price target lowered to $9 from $10 at Piper Sandler 03/09/23 DA Davidson BigCommerce started with Neutral at DA Davidson on heavy SMB exposure GLBE Global-e Online $34.73 / -0.16 (-0.46%) 05/23/23 Raymond James Global-e Online price target raised to $40 from $35 at Raymond James 05/22/23 Jefferies Global-e Online price target raised to $40 from $35 at Jefferies 04/05/23 KeyBanc Global-e Online price target raised to $40 from $35 at KeyBanc SHOP GLBE BIGC SHOP Shopify $58.28 / +0.37 (+0.64%) 05/04/23 Shopify sees Q2 revenue growth rate similar to Q1 05/04/23 Shopify reports Q1 adjusted EPS 1c, consensus (4c) 02/15/23 Shopify sees Q1 revenue growth in high teens percentages 02/15/23 Shopify reports Q4 adjusted EPS 7c, consensus (1c) GLBE Global-e Online $34.73 / -0.16 (-0.46%) 05/22/23 Global-e Online raises FY23 revenue view $562M-$590M from $557M-$584M 05/22/23 Global-e Online sees Q2 revenue $125M-$130M, consensus $128.02M 05/22/23 Global-e Online reports Q1 EPS (26c), consensus (29c) 02/22/23 Global-e Online sees Q1 revenue $108M-$114M, consensus $111.91M BIGC BigCommerce $9.35 / +0.485 (+5.47%) 05/04/23 BigCommerce narrows FY23 revenue to $303M-$311M from $301M-$313M 05/04/23 BigCommerce sees Q2 revenue $72.1M-$74.1M, consensus $73.96M 05/04/23 BigCommerce reports Q1 EPS (30c), consensus (13c) 02/23/23 BigCommerce sees FY23 revenue $301M-$313M, consensus $318.59M SHOP SHOP Shopify $58.28 / +0.37 (+0.64%) 05/26/23 Shopify nominates Bret Taylor for board seat, The Information says 01/27/23 Shopify CTO Allan Leinwand to depart company, Insider reports 01/03/23 Shopify Audiences a 'key focus' for company, FT reports SHOP GLBE BIGC SHOP Shopify $58.28 / +0.37 (+0.64%) 05/26/23 Buy/Sell: Wall Street's top 10 stock calls this week 05/24/23 What You Missed On Wall Street On Wednesday 05/24/23 What You Missed On Wall Street This Morning 05/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations GLBE Global-e Online $34.73 / -0.16 (-0.46%) 05/22/23 What You Missed On Wall Street On Monday 05/22/23 What You Missed On Wall Street This Morning 05/22/23 Fly Intel: Pre-market Movers BIGC BigCommerce $9.35 / +0.485 (+5.47%) 05/05/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/07/23 What You Missed On Wall Street On Tuesday 02/07/23 What You Missed On Wall Street This Morning SHOP SHOP Shopify $58.28 / +0.37 (+0.64%) 05/23/23 Largest borrow rate increases among liquid names 05/09/23 Unusually active option classes on open May 9th 05/05/23 Notable open interest changes for May 5th 05/04/23 Unusually active option classes on open May 4th
Syndicate	Beam Global files $150M mixed securities shelf 17:25 06/02/23 06/02 17:25 06/02/23 17:25 BEEM Beam Global $11.91 / +0.16 (+1.36%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BEEM Beam Global $11.91 / +0.16 (+1.36%) 05/11/23 Beam issued European patent for compact transportation-configurable EV ARC 04/18/23 Beam Global receives order fo EV ARC solar-powered EV charging systems 04/11/23 Beam receives multi-million dollar battery module order industrial product line 03/23/23 Beam Global secures $100M credit facility BEEM Beam Global $11.91 / +0.16 (+1.36%) 03/30/23 Needham Beam Global reinstated with a Hold at Needham 02/13/23 Northland Beam Global initiated with an Outperform at Northland 11/14/22 H.C. Wainwright Beam Global upgraded to Buy from Neutral at H.C. Wainwright 08/15/22 Maxim Beam Global price target lowered to $40 from $50 at Maxim BEEM Beam Global $11.91 / +0.16 (+1.36%) 05/15/23 Beam Global Reports Q1 EPS (38c), consensus (42c) 03/29/23 Beam Global reports Q4 EPS (77c), consensus (41c) BEEM Beam Global $11.91 / +0.16 (+1.36%) 05/16/23 Fly Intel: Pre-market Movers 05/15/23 Fly Intel: After-Hours Movers 03/29/23 Fly Intel: After-Hours Movers 02/13/23 What You Missed This Week in EVs and Clean Energy 09/19/23 Institutional Investor Conference 2023
Hot Stocks	Dish to replace Cutera in S&P 600 at open on 6/20 17:19 06/02/23 06/02 17:19 06/02/23 17:19 DISH Dish $7.31 / +1.03 (+16.41%) , CUTR Cutera $17.14 / +0.135 (+0.79%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DISH CUTR DISH Dish $7.31 / +1.03 (+16.41%) 06/02/23 Palo Alto Networks to replace Dish in S&P 500 at open on 6/20 05/25/23 Dish jumps 20% after WSJ report on mobile plan talks with Amazon 05/18/23 FCC votes to preserve spectrum between 12.2-12.7 GHz 05/16/23 Dish jumps 6% after director insider transactions CUTR Cutera $17.14 / +0.135 (+0.79%) 05/12/23 Cutera comments on termination of poxy solicitation by Voce Capital 05/11/23 Cutera shareholder Voce Capital terminates proxy solicitation 05/09/23 Cutera announces agreements with Pura Vida, RTW 04/18/23 Plants, Mowry say Cutera special committee made 'misleading' statements DISH CUTR DISH Dish $7.31 / +1.03 (+16.41%) 06/02/23 JPMorgan JPMorgan 'most comfortable defending' T-Mobile after Amazon wireless headlines 05/25/23 KeyBanc Dish, Amazon deal may be viewed negatively for AT&T, says at KeyBanc 05/25/23 Citi Citi downgrades Dish to Neutral on 'substantial capital needs' 05/24/23 Citi Dish downgraded to Neutral from Buy at Citi CUTR Cutera $17.14 / +0.135 (+0.79%) 05/11/23 William Blair Cutera downgraded to Market Perform from Outperform at William Blair 05/10/23 Cantor Fitzgerald Cutera price target lowered to $21 from $33 at Cantor Fitzgerald 05/10/23 Piper Sandler Cutera reinstated with an Underweight at Piper Sandler 03/30/23 Maxim Cutera downgraded to Hold from Buy at Maxim DISH CUTR DISH Dish $7.31 / +1.03 (+16.41%) 05/08/23 Dish reports Q1 EPS 35c, consensus 36c 02/23/23 Dish reports Q4 EPS $1.47, consensus 47c 02/22/23 Notable companies reporting before tomorrow's open CUTR Cutera $17.14 / +0.135 (+0.79%) 05/09/23 Cutera reports Q1 EPS ($1.26), consensus (39c) 04/12/23 Cutera withdraws FY23 outlook 02/28/23 Cutera sees FY23 revenue $277M-$292M, consensus $300.7M 02/28/23 Cutera reports Q4 EPS (40c), consensus (24c) DISH DISH Dish $7.31 / +1.03 (+16.41%) 06/02/23 Amazon tells Reuters 'don't have plans to add wireless at this time' 06/02/23 Amazon in talks to offer low-cost or free Prime phone service, Bloomberg says 05/25/23 Dish in discussions to sell wireless plans via Amazon, WSJ reports 05/18/23 Ergen flew to Dubai to seek cash for struggling Dish, NY Post says DISH CUTR DISH Dish $7.31 / +1.03 (+16.41%) 05/25/23 What You Missed On Wall Street On Thursday 05/25/23 What You Missed On Wall Street This Morning 05/25/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/08/23 What You Missed On Wall Street On Monday CUTR Cutera $17.14 / +0.135 (+0.79%) 05/09/23 Fly Intel: After-Hours Movers 04/30/23 Short Report: Bears boost Vivid Seats position to record high as stock bottoms 04/12/23 What You Missed On Wall Street On Wednesday 04/12/23 What You Missed On Wall Street This Morning 06/09/23 Cutera Inc DISH DISH Dish $7.31 / +1.03 (+16.41%) 06/02/23 Dish Network call volume above normal and directionally bullish 06/02/23 Early notable gainers among liquid option names on June 2nd 05/16/23 Early notable gainers among liquid option names on May 16th 03/09/23 Early notable gainers among liquid option names on March 9th
Hot Stocks	Lockheed Martin awarded $122.21M Space Force contract modification » 17:19 06/02/23 06/02 17:19 06/02/23 17:19 LMT Lockheed Martin $454.44 / +5.205 (+1.16%) Lockheed Martin has been… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 17:19 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options LMT Lockheed Martin $454.44 / +5.205 (+1.16%) 06/01/23 Lockheed Martin awarded $240M Air Force contract 06/01/23 Lockheed Martin sees F-35 reaching annual output of 156 within two years 06/01/23 Lockheed Martin sees U.S. defense spending up 3%/year with debt deal, CEO says 05/23/23 Lockheed Martin awarded $194.74M Navy contract LMT Lockheed Martin $454.44 / +5.205 (+1.16%) 05/30/23 Citi Citi expects defense stocks to rally on debt ceiling deal 04/20/23 Bernstein Lockheed Martin price target raised to $496 from $478 at Bernstein 04/19/23 Credit Suisse Lockheed Martin price target raised to $550 from $510 at Credit Suisse 04/19/23 Citi Lockheed Martin price target raised to $579 from $546 at Citi LMT Lockheed Martin $454.44 / +5.205 (+1.16%) 04/18/23 Lockheed Martin reports Q1 adjusted EPS $6.43, consensus $6.06 04/18/23 Lockheed Martin backs FY23 EPS view about $26.60-$26.90, consensus $26.77 04/18/23 Lockheed Martin reports Q1 EPS $6.61, consensus $6.06 04/17/23 Notable companies reporting before tomorrow's open LMT Lockheed Martin $454.44 / +5.205 (+1.16%) 05/18/23 USAF opens multibillion-dollar contest for new fighter aircraft, Bloomberg says 05/14/23 Space could be a $1T business, Barron's says 04/25/23 NASA selects Boeing, Aerojet, others to collaborate on key tech development 04/18/23 China bans Raytheon, Lockheed executives from country, Reuters says LMT Lockheed Martin $454.44 / +5.205 (+1.16%) 04/18/23 What You Missed On Wall Street On Tuesday 04/18/23 What You Missed On Wall Street This Morning 04/18/23 Fly Intel: Pre-market Movers 04/12/23 What You Missed On Wall Street On Wednesday LMT Lockheed Martin $454.44 / +5.205 (+1.16%) 04/18/23 Early notable gainers among liquid option names on April 18th 02/13/23 Unusually active option classes on open February 13th 01/24/23 Unusually active option classes on open January 24th
Hot Stocks	Palo Alto Networks to replace Dish in S&P 500 at open on 6/20 17:18 06/02/23 06/02 17:18 06/02/23 17:18 PANW Palo Alto Networks $217.23 / +0.475 (+0.22%) , DISH Dish $7.31 / +1.03 (+16.41%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PANW DISH PANW Palo Alto Networks $217.23 / +0.475 (+0.22%) 05/23/23 Palo Alto Networks expects supply chains to normalize exiting FY23 05/23/23 Palo Alto Networks says deal scrutiny has increased 05/23/23 Palo Alto Networks sees FY23 adjusted free cash flow margin 37.5%-38.5% 04/25/23 Accenture, Palo Alto Networks collaborate to deliver SASE solutions DISH Dish $7.31 / +1.03 (+16.41%) 05/25/23 Dish jumps 20% after WSJ report on mobile plan talks with Amazon 05/18/23 FCC votes to preserve spectrum between 12.2-12.7 GHz 05/16/23 Dish jumps 6% after director insider transactions 05/08/23 Dish says it has 'narrow window of opportunity' to address capital structure PANW DISH PANW Palo Alto Networks $217.23 / +0.475 (+0.22%) 06/02/23 Stephens SentinelOne downgraded to Equal Weight from Overweight at Stephens 05/30/23 RBC Capital Crowdstrike price target raised to $180 from $170 at RBC Capital 05/24/23 Deutsche Bank Palo Alto Networks price target raised to $225 from $210 at Deutsche Bank 05/24/23 Loop Capital Palo Alto Networks price target raised to $240 from $225 at Loop Capital DISH Dish $7.31 / +1.03 (+16.41%) 06/02/23 JPMorgan JPMorgan 'most comfortable defending' T-Mobile after Amazon wireless headlines 05/25/23 KeyBanc Dish, Amazon deal may be viewed negatively for AT&T, says at KeyBanc 05/25/23 Citi Citi downgrades Dish to Neutral on 'substantial capital needs' 05/24/23 Citi Dish downgraded to Neutral from Buy at Citi PANW DISH PANW Palo Alto Networks $217.23 / +0.475 (+0.22%) 05/23/23 Palo Alto Networks raises FY23 adjusted EPS view to $4.25-$4.29 from $3.97-$4.03 05/23/23 Palo Alto Networks sees Q4 adjusted EPS $1.26-$1.30, consensus $1.20 05/23/23 Palo Alto Networks reports Q3 adjusted EPS $1.10, consensus 93c 05/23/23 Notable companies reporting after market close DISH Dish $7.31 / +1.03 (+16.41%) 05/08/23 Dish reports Q1 EPS 35c, consensus 36c 02/23/23 Dish reports Q4 EPS $1.47, consensus 47c 02/22/23 Notable companies reporting before tomorrow's open PANW DISH PANW Palo Alto Networks $217.23 / +0.475 (+0.22%) 03/15/23 Microsoft says Russia's spring offensive may include new cyberattacks, NYT says 01/06/23 White House to unveil cybersecurity strategy, Washington Post reports DISH Dish $7.31 / +1.03 (+16.41%) 06/02/23 Amazon tells Reuters 'don't have plans to add wireless at this time' 06/02/23 Amazon in talks to offer low-cost or free Prime phone service, Bloomberg says 05/25/23 Dish in discussions to sell wireless plans via Amazon, WSJ reports 05/18/23 Ergen flew to Dubai to seek cash for struggling Dish, NY Post says PANW DISH PANW Palo Alto Networks $217.23 / +0.475 (+0.22%) 05/24/23 What You Missed On Wall Street On Wednesday 05/24/23 What You Missed On Wall Street This Morning 05/24/23 Fly Intel: Pre-market Movers 05/23/23 Fly Intel: After-Hours Movers DISH Dish $7.31 / +1.03 (+16.41%) 05/25/23 What You Missed On Wall Street On Thursday 05/25/23 What You Missed On Wall Street This Morning 05/25/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/08/23 What You Missed On Wall Street On Monday PANW DISH PANW Palo Alto Networks $217.23 / +0.475 (+0.22%) 06/01/23 Unusually active option classes on open June 1st 05/23/23 Palo Alto Networks options imply 6.8% move in share price post-earnings 02/21/23 Palo Alto Networks options imply 6.7% move in share price post-earnings DISH Dish $7.31 / +1.03 (+16.41%) 06/02/23 Dish Network call volume above normal and directionally bullish 06/02/23 Early notable gainers among liquid option names on June 2nd 05/16/23 Early notable gainers among liquid option names on May 16th 03/09/23 Early notable gainers among liquid option names on March 9th
Hot Stocks	Raytheon Technologies awarded $263.72M Navy contract modification » 17:15 06/02/23 06/02 17:15 06/02/23 17:15 RTX Raytheon Technologies $96.08 / +1.99 (+2.11%) Raytheon was awarded a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 17:15 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options RTX Raytheon Technologies $96.08 / +1.99 (+2.11%) 06/01/23 Raytheon Technologies awarded $621.4M Missile Defense Agency contract 05/25/23 Raytheon Technologies awarded $146.66M Navy contract 05/25/23 Raytheon Technologies awarded contract to modernize SPY-6 hardware 05/08/23 CPI Aerostructures gets manufacturing authorization from Raytheon Technologies RTX Raytheon Technologies $96.08 / +1.99 (+2.11%) 04/26/23 Citi Raytheon Technologies price target raised to $113.50 from $106 at Citi 04/26/23 Susquehanna Raytheon Technologies price target raised to $117 from $116 at Susquehanna 04/26/23 Baird Raytheon Technologies price target raised to $115 from $106 at Baird 04/20/23 Jefferies Raytheon downgraded to Hold at Jefferies on Defense and P&W concerns RTX Raytheon Technologies $96.08 / +1.99 (+2.11%) 04/25/23 Raytheon Technologies backs FY23 adjusted EPS view $4.90-$5.05, consensus $5.01 04/25/23 Raytheon Technologies reports Q1 adjusted EPS $1.22, consensus $1.13 04/24/23 Notable companies reporting before tomorrow's open RTX Raytheon Technologies $96.08 / +1.99 (+2.11%) 05/25/23 Embraer voices 'full support' for Pratt & Whitney, Reuters reports 04/18/23 China bans Raytheon, Lockheed executives from country, Reuters says 03/07/23 Biden to propose Pentagon budget of over $835B, Bloomberg says 01/06/23 McCarthy's speaker deal includes $75B defense cut, Bloomberg reports RTX Raytheon Technologies $96.08 / +1.99 (+2.11%) 04/25/23 Fly Intel: Pre-market Movers 04/20/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/16/23 What You Missed On Wall Street This Morning 01/13/23 What You Missed On Wall Street This Morning RTX Raytheon Technologies $96.08 / +1.99 (+2.11%) 04/12/23 Early notable gainers among liquid option names on April 12th
Hot Stocks	LoanDepot names Hayes CFO, consolidates LDI Digital into existing channels » 17:01 06/02/23 06/02 17:01 06/02/23 17:01 LDI LoanDepot $1.91 / +0.03 (+1.60%) As part of its previously… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 17:01 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options LDI LoanDepot $1.91 / +0.03 (+1.60%) 05/30/23 LoanDepot names Alec Hanson chief marketing officer 03/15/23 Anthony Hsieh urges LoanDepot board to 'cease wasting' stockholder capital 03/09/23 Anthony Hsieh nominates Steve Ozonian to loanDepot board 02/08/23 LoanDepot announces Anthony Hsieh stepped down as Executive Chairman LDI LoanDepot $1.91 / +0.03 (+1.60%) 03/09/23 William Blair LoanDepot downgraded on higher interest rates at William Blair 03/09/23 William Blair LoanDepot downgraded to Market Perform from Outperform at William Blair 01/09/23 Credit Suisse LoanDepot downgraded to Neutral from Outperform at Credit Suisse 11/09/22 Citi LoanDepot price target lowered to $1.25 from $1.50 at Citi LDI LoanDepot $1.91 / +0.03 (+1.60%) 05/09/23 LoanDepot reports Q1 EPS (25c), consensus (23c) 03/08/23 LoanDepot reports Q4 EPS (46c), consensus (26c) LDI LoanDepot $1.91 / +0.03 (+1.60%) 03/09/23 What You Missed On Wall Street On Thursday 03/09/23 What You Missed On Wall Street This Morning 06/07/23 loanDepot, Inc. LDI LoanDepot $1.91 / +0.03 (+1.60%) 02/14/23 loanDepot options imply 4.9% move in share price post-earnings
Hot Stocks	Churchill Downs suspends operations at racetrack due to equine deaths » 17:00 06/02/23 06/02 17:00 06/02/23 17:00 CHDN Churchill Downs $142.10 / +4.82 (+3.51%) Churchill Downs announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 17:00 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly CHDN Churchill Downs $142.10 / +4.82 (+3.51%) 05/31/23 Nevada reports April statewide gaming win up 2.77% to $1.16B 04/25/23 Churchill Downs announces two-for-one stock split 04/25/23 Nevada reports March statewide gaming win down 3.18% to $1.31B 03/29/23 DraftKings launches DK Horse app CHDN Churchill Downs $142.10 / +4.82 (+3.51%) 04/28/23 JMP Securities Churchill Downs price target raised to $326 from $298 at JMP Securities 04/17/23 JMP Securities Churchill Downs price target raised to $298 from $273 at JMP Securities 03/17/23 Truist Truist starts 'best growth story in gaming' Churchill Downs at Buy 03/17/23 Truist Churchill Downs initiated with a Buy at Truist CHDN Churchill Downs $142.10 / +4.82 (+3.51%) 02/22/23 Churchill Downs reports Q4 adjusted EPS $1.46, consensus $1.67 CHDN Churchill Downs $142.10 / +4.82 (+3.51%) 05/08/23 Seventh horse dies at Churchill Downs ahead of Kentucky Derby, NYT reports CHDN Churchill Downs $142.10 / +4.82 (+3.51%) 06/02/23 Bet On It: Online sports betting bill okayed by Senate in North Carolina 05/26/23 Bet On It: MGM Resorts considered potential buyer for Kindred Group 05/19/23 Bet On It: Fanatics buys U.S. operations from PointsBet 05/12/23 Bet On It: Churchill Downs posts all-time high Kentucky Derby wagers

General news	Treasury Market Summary: » 16:55 06/02/23 06/02 16:55 06/02/23 16:55 $ECON Economic Data / + Treasury Market Summary:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 16:55 Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Technical Analysis $ECON Economic Data / + 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/01/23 Einhorn says investors should be 'bearish on stocks and bullish on inflation' $ECON Economic Data / + $ECON Economic Data / + 05/25/23 Biden, McCarthy edging close to debt ceiling deal, Reuters reports 03/29/23 Powell did not 'predict' another rate hike in meeting, CNBC reports 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says $ECON Economic Data / + 05/31/23 What You Missed On Wall Street On Wednesday 05/24/23 What You Missed On Wall Street On Wednesday 05/03/23 What You Missed On Wall Street On Wednesday 04/19/23 What You Missed On Wall Street On Wednesday $ECON Economic Data / + 03/22/23 Fed says 'additional policy firming may be appropriate'
Conference/Events	Alpha & Omega management to meet with Benchmark » 16:51 06/02/23 06/02 16:51 06/02/23 16:51 AOSL Alpha & Omega $28.65 / +0.75 (+2.69%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 16:51 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events AOSL Alpha & Omega $28.65 / +0.75 (+2.69%) 03/12/23 Alpha & Omega issues statement on Silicon Valley Bank 02/07/23 Alpha & Omega announces silicon carbide license deal, supply agreement 02/07/23 Alpha & Omega falls after quarterly results, guidance miss estimates 12/07/22 Alpha & Omega announces executive leadership transition AOSL Alpha & Omega $28.65 / +0.75 (+2.69%) 04/19/23 Stifel Alpha & Omega price target lowered to $22 from $27 at Stifel 02/07/23 B. Riley Alpha & Omega price target lowered to $34 from $36 at B. Riley 10/04/22 B. Riley Alpha & Omega price target lowered to $38 from $45 at B. Riley 08/11/22 B. Riley Alpha & Omega price target raised to $45 from $42 at B. Riley AOSL Alpha & Omega $28.65 / +0.75 (+2.69%) 05/04/23 Alpha & Omega sees Q4 revenue $160M, plus or minus $5M, consensus $155.8M 05/04/23 Alpha & Omega reports Q3 adjusted EPS (21c), consensus (19c) 05/04/23 Alpha & Omega reports Q3 adjusted EPS (21c), consensus (19c) 02/06/23 Alpha & Omega sees Q3 revenue $125M-$135M , consensus $193.8M AOSL Alpha & Omega $28.65 / +0.75 (+2.69%) 02/06/23 Fly Intel: After-Hours Movers 06/08/23 Alpha & Omega 06/09/23 Alpha & Omega
Conference/Events	Truist leisure/lodging analyst holds an analyst/industry conference call » 16:47 06/02/23 06/02 16:47 06/02/23 16:47 CSGP CoStar Group $81.90 / +2.24 (+2.81%) Lodging Analyst Scholes,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 16:47 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options CSGP CoStar Group $81.90 / +2.24 (+2.81%) 02/21/23 News Corp no longer in discussions with CoStar over potential Move sale 12/12/22 CoStar Group to be added to Nasdaq 100 index CSGP CoStar Group $81.90 / +2.24 (+2.81%) 04/26/23 Needham CoStar Group price target raised to $90 from $80 at Needham 02/22/23 Needham CoStar Group price target lowered to $80 from $95 at Needham 02/22/23 Truist CoStar Group price target lowered to $85 from $95 at Truist 02/22/23 Stephens CoStar Group price target lowered to $86 from $90 at Stephens CSGP CoStar Group $81.90 / +2.24 (+2.81%) 04/25/23 CoStar Group reports Q1 adjusted EPS 29c, consensus 25c 04/25/23 CoStar Group sees FY23 adjusted EPS $1.21-$1.24, consensus $1.09 04/25/23 CoStar Group sees Q2 adjusted EPS 29c-30c, consensus 26c 04/25/23 CoStar Group reports Q1 EPS 21c, consensus 25c 19 Sep CSGP CoStar Group $81.90 / +2.24 (+2.81%) 01/25/23 National Association of Realtors a hurdle for Move Inc. sale, Bloomberg says 01/24/23 News Corp. in discussions to sell 80% Move stake to CoStar, FT reports CSGP CoStar Group $81.90 / +2.24 (+2.81%) 02/22/23 What You Missed On Wall Street On Wednesday 02/22/23 What You Missed On Wall Street This Morning 02/22/23 Fly Intel: Pre-market Movers 02/21/23 Fly Intel: After-Hours Movers 06/09/23 Lodging/Leisure 06/08/23 CoStar Group, Inc. CSGP CoStar Group $81.90 / +2.24 (+2.81%) 04/26/23 Early notable gainers among liquid option names on April 26th
Hot Stocks	Best Buy CEO Barry sells 17,382 common shares » 16:45 06/02/23 06/02 16:45 06/02/23 16:45 BBY Best Buy $73.19 / +0.285 (+0.39%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 16:45 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BBY Best Buy $73.19 / +0.285 (+0.39%) 05/25/23 Best Buy sees Q2 comparable sales decline 6% to 8% 05/25/23 Best Buy reports Q1 SSS down 10.1% 03/22/23 Best Buy CEO sells $1.99M in common stock 03/10/23 Roku, Best Buy enter first-to-market relationship across ad, retail businesses BBY Best Buy $73.19 / +0.285 (+0.39%) 05/26/23 Truist Best Buy price target lowered to $77 from $88 at Truist 05/26/23 DA Davidson Best Buy price target lowered to $87 from $96 at DA Davidson 05/26/23 Wells Fargo Best Buy price target lowered to $75 from $80 at Wells Fargo BBY Best Buy $73.19 / +0.285 (+0.39%) 05/25/23 Best Buy backs FY24 EPS $5.70-$6.50, consensus $6.17 05/25/23 Best Buy reports Q1 EPS $1.15, consensus $1.11 05/24/23 Notable companies reporting before tomorrow's open BBY Best Buy $73.19 / +0.285 (+0.39%) 04/14/23 Best Buy cutting jobs at stores as sales move online, WSJ reports 01/20/23 Apple starts job cuts in some retail channels, AppleInsider reports 01/10/23 Best Buy announces new free shipping feature, CNET reports 01/10/23 Best Buy-owned Lively faces complaints after 3G shutdown, WSJ reports BBY Best Buy $73.19 / +0.285 (+0.39%) 05/25/23 What You Missed On Wall Street On Thursday 05/25/23 What You Missed On Wall Street This Morning 05/25/23 Fly Intel: Pre-market Movers 03/07/23 What You Missed On Wall Street On Tuesday 06/14/23 Best Buy Co. Inc. BBY Best Buy $73.19 / +0.285 (+0.39%) 05/25/23 Unusually active option classes on open May 25th 04/25/23 Best Buy put volume heavy and directionally bearish 04/24/23 Best Buy put volume heavy and directionally bearish 04/05/23 Best Buy put volume heavy and directionally bearish
Conference/Events	Cantor Fitzgerald biotech analyst to hold analyst/industry conference call » 16:39 06/02/23 06/02 16:39 06/02/23 16:39 ONCY Oncolytics $1.70 / +0.05 (+3.03%) , IMAB I-Mab $3.18 / +0.145 (+4.78%) , HCM Hutchmed $12.47 / +0.35 (+2.89%) , PDSB PDS Biotechnology $9.40 / -0.5 (-5.05%) , EFTR eFfector Therapeutics $1.17 / +0.13 (+12.50%) , ARAV Aravive $1.80 / +0.04 (+2.27%) , JNJ Johnson & Johnson $156.98 / +2.44 (+1.58%) , BMY Bristol-Myers $65.66 / +0.98 (+1.52%) , REGN Regeneron $740.00 / +8.995 (+1.23%) , GILD Gilead $77.88 / +1.665 (+2.18%) , NVS Novartis $98.90 / +1.79 (+1.84%) , MBIO Mustang Bio $5.60 / -0.71 (-11.25%) Biotechnology Analysts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 16:39 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options REGN PDSB ONCY NVS MBIO JNJ IMAB HCM GILD EFTR BMY ARAV REGN Regeneron $740.00 / +8.995 (+1.23%) 05/25/23 Regeneron says updated Linvoseltamab data demonstrates durable responses 05/25/23 Regeneron reports 'positive' data from Fianlimab-Libtayo combo trial 05/21/23 Regeneron, Sanofi present Dupixent late-breaking Phase 3 COPD results 05/18/23 Sanofi 'pleased' with Supreme Court's ruling on Amgen's asserted patent claims PDSB PDS Biotechnology $9.40 / -0.5 (-5.05%) 05/25/23 PDS Biotechnology announces 'promising' interim data from VERSATILE-002 trial 05/18/23 PDS Biotechnology completes enrollment in VERSATILE-002 Phase 2 trial 05/15/23 PDS Biotechnology expects cash to fund programs into 3Q24 04/27/23 PDS Biotechnology to present updated data from VERSATILE-002 study ONCY Oncolytics $1.70 / +0.05 (+3.03%) 05/25/23 Oncolytics reports positive response data in Phase 2 breast cancer trial 12/08/22 Oncolytics' Chinese partner presents interim data on breast cancer candidate NVS Novartis $98.90 / +1.79 (+1.84%) 06/02/23 Novartis says Kisqali reduced risk of breast cancer recurrence by 25% in study 06/01/23 Pharming to sell PRV to Novartis for $21.1M 05/25/23 EMA accepts Sandoz marketing authorization applications for biosimilar denosumab 05/22/23 Avrobio to sell HSC gene therapy program to Novartis for $87.5M in cash MBIO Mustang Bio $5.60 / -0.71 (-11.25%) 05/18/23 Mustang Bio announces strategic manufacturing partnership, portfolio updates 04/03/23 Mustang Bio announces 15-for-1 reverse stock split 12/19/22 Mustang Bio provides CAR T cell therapy portfolio updates JNJ Johnson & Johnson $156.98 / +2.44 (+1.58%) 05/31/23 Janssen says Tremfya showed 'sustainable improvements' in psoriatic arthritis 05/25/23 Legend: Type II variation application submitted to EMA for CARVYKTI 05/25/23 Bristol-Myers granted FDA Fast Track Designation for 3 milvexian indications 05/12/23 Protagonist and Janssen report data from preclinical studies of JNJ-2113 IMAB I-Mab $3.18 / +0.145 (+4.78%) 05/25/23 I-Mab announces results from CD73 antibody combination study 04/25/23 Tracon announces $23M arbitration award in dispute with I-Mab 04/25/23 I-Mab receives arbitration award relating to Tracon CD73 antibody pact 04/24/23 I-Mab doses first patient in Phase 3 study of lemzoparlimab in MDS in China HCM Hutchmed $12.47 / +0.35 (+2.89%) 05/25/23 Takeda, Hutchmed say Fruquintinib NDA granted priority review by FDA 04/17/23 Hutchmed announces NDA acceptance for Fruquintinib in China 04/04/23 Hutchmed initiates registration phase of HMPL-453 trial 03/14/23 Hutchmed announces closing of fruquintinib license to Takeda GILD Gilead $77.88 / +1.665 (+2.18%) 05/26/23 Gilead announces CHMP reccomendation for the use of Veklury 05/17/23 Gilead to present advances across its oncology pipeline at ASCO Annual Meeting 05/15/23 Arcus Biosciences jumps 2% amid expanded inflammation pact with Gilead 05/15/23 Expanded Gilead- Arcus pact may result in up to $1B in payments to Arcus EFTR eFfector Therapeutics $1.17 / +0.13 (+12.50%) 05/25/23 eFfector Therapeutics' zotatifin shows positive Phase 2 breast cancer results 04/11/23 eFfector Therapeutics to collaborate with Standford Medicine 02/21/23 eFfector announces top-line results from Phase 1b trial of zotatifin 01/05/23 eFfector Therapeutics provides clinical data update for Zotatifin BMY Bristol-Myers $65.66 / +0.98 (+1.52%) 05/30/23 Bristol-Myers' repotrectinib application in lung cancer accepted by FDA 05/26/23 Bristol-Myers reports CHMP opinion recommending approval for Opdivo combination 05/25/23 Bristol-Myers to present first results from Phase 3 COMMANDS study of Reblozyl 05/25/23 Bristol-Myers says Breyanzi first and only CAR-T to deliver efficacy in CLL/SLL ARAV Aravive $1.80 / +0.04 (+2.27%) 05/25/23 Aravive to present 'promising' update from phase 2 trial of Batiraxcept at ASCO 05/16/23 Aravive announces Phase 3 trial design for batiraxcept 05/08/23 Aravive to host virtual KOL event on batiraxcept 04/26/23 Aravive announces poster presentation at ASCO ONCY IMAB HCM PDSB EFTR ARAV JNJ BMY REGN GILD NVS MBIO ONCY Oncolytics $1.70 / +0.05 (+3.03%) 05/23/23 JonesResearch Oncolytics initiated with a Buy at JonesResearch 03/06/23 Canaccord Oncolytics price target lowered to $5.00 from $6.00 at Canaccord 03/06/23 Cantor Fitzgerald Oncolytics initiated with an Overweight at Cantor Fitzgerald IMAB I-Mab $3.18 / +0.145 (+4.78%) 04/03/23 Piper Sandler I-Mab price target lowered to $25 from $30 at Piper Sandler 04/03/23 H.C. Wainwright I-Mab price target lowered to $25 from $45 at H.C. Wainwright 08/31/22 H.C. Wainwright I-Mab price target lowered to $45 from $70 at H.C. Wainwright 08/30/22 Piper Sandler I-Mab price target lowered to $30 from $35 at Piper Sandler HCM Hutchmed $12.47 / +0.35 (+2.89%) PDSB PDS Biotechnology $9.40 / -0.5 (-5.05%) 02/27/23 H.C. Wainwright H.C. Wainwright reiterates Buy on PDS following positive FDA meeting 01/03/23 H.C. Wainwright PDS Biotechnology price target raised to $21 from $15 at H.C. Wainwright 12/28/22 B. Riley PDS Biotechnology price target raised to $12 from $10 at B. Riley 11/14/22 Chardan PDS Biotechnology price target raised to $16 from $15 at Chardan EFTR eFfector Therapeutics $1.17 / +0.13 (+12.50%) 05/26/23 Mizuho eFfector Therapeutics posted positive breast cancer data, says Mizuho 05/26/23 Stifel eFfector Therapeutics upgraded to Buy from Hold at Stifel ARAV Aravive $1.80 / +0.04 (+2.27%) 03/15/23 H.C. Wainwright Aravive price target raised to $12 from $7 at H.C. Wainwright 01/04/23 EF Hutton Aravive initiated with a Buy at EF Hutton 11/13/22 Piper Sandler Aravive price target lowered to $2 from $6 at Piper Sandler 10/27/22 Roth MKM Aravive price target lowered to $10 from $15 at Roth Capital JNJ Johnson & Johnson $156.98 / +2.44 (+1.58%) 05/30/23 RBC Capital Kenvue initiated with an Outperform at RBC Capital 05/30/23 Citi Johnson & Johnson resumed with a Buy at Citi 05/30/23 JPMorgan JPMorgan starts Kenvue with Overweight on 'resilient growth' 05/30/23 Goldman Sachs Kenvue initiated with a Neutral at Goldman Sachs BMY Bristol-Myers $65.66 / +0.98 (+1.52%) 05/01/23 Barclays Bristol-Myers price target lowered to $65 from $66 at Barclays 04/28/23 Credit Suisse Bristol-Myers price target lowered to $72 from $78 at Credit Suisse 04/21/23 BofA Bristol-Myers price target raised to $85 from $82 at BofA 04/20/23 H.C. Wainwright Legend Biotech price target raised to $77 from $66 at H.C. Wainwright REGN Regeneron $740.00 / +8.995 (+1.23%) 05/19/23 Piper Sandler Regeneron Q1 Eylea miss 'not about share, says Piper Sandler 05/08/23 Guggenheim Regeneron price target lowered to $935 from $960 at Guggenheim 05/05/23 Morgan Stanley Regeneron price target raised to $927 from $880 at Morgan Stanley 05/05/23 SVB Securities Regeneron price target lowered to $895 from $976 at SVB Securities GILD Gilead $77.88 / +1.665 (+2.18%) 06/02/23 Argus Gilead continues to make regulatory progress, says Argus 05/16/23 BMO Capital Gilead upgraded to Outperform from Market Perform at BMO Capital 04/28/23 Piper Sandler Gilead assumed with an Overweight at Piper Sandler 04/12/23 Morgan Stanley Gilead price target raised to $85 from $81 at Morgan Stanley NVS Novartis $98.90 / +1.79 (+1.84%) 05/19/23 JPMorgan JPMorgan places 'Negative Catalyst Watch' on Novartis into data 04/26/23 Barclays Novartis price target raised to CHF 90 from CHF 85 at Barclays 04/26/23 Credit Suisse Novartis price target raised to CHF 90 from CHF 80 at Credit Suisse 04/26/23 JPMorgan Novartis price target raised to CHF 92 from CHF 85 at JPMorgan MBIO Mustang Bio $5.60 / -0.71 (-11.25%) 05/26/23 B. Riley Mustang Bio price target raised to $10 from $4 at B. Riley 11/16/22 BTIG Mustang Bio price target lowered to $4 from $8 at BTIG 08/17/22 BTIG Bluebird's approval has positive read for Mustang Bio, says BTIG 07/14/22 B. Riley Mustang Bio price target lowered to $4 from $5 at B. Riley REGN PDSB ONCY NVS MBIO JNJ GILD EFTR BMY ARAV REGN Regeneron $740.00 / +8.995 (+1.23%) 05/04/23 Regeneron reports Q1 adjusted EPS $10.09, consensus $9.56 02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open PDSB PDS Biotechnology $9.40 / -0.5 (-5.05%) 05/15/23 PDS Biotechnology reports Q1 EPS (32c), consensus (31c) 03/28/23 PDS Biotechnology reports 2022 EPS ($1.43), consensus ($1.08) ONCY Oncolytics $1.70 / +0.05 (+3.03%) 03/03/23 Oncolytics reports Q4 EPS (C$0.14) vs. (C$0.14) last year NVS Novartis $98.90 / +1.79 (+1.84%) 04/25/23 Novartis reports Q1 EPS $1.71, consensus $1.55 02/01/23 Novartis sees core operating income to grow mid single digit percentage in 2023 02/01/23 Novartis reports Q4 core EPS $1.52, consensus $1.44 MBIO Mustang Bio $5.60 / -0.71 (-11.25%) 05/12/23 Mustang Bio reports Q1 EPS ($2.06) vs. ($2.71) last year JNJ Johnson & Johnson $156.98 / +2.44 (+1.58%) 04/18/23 Johnson & Johnson raises FY23 adjusted EPS to $10.60-$10.70 from $10.45-$10.65 04/18/23 Johnson & Johnson reports Q1 adjusted EPS $2.68, consensus $2.51 04/17/23 Notable companies reporting before tomorrow's open 02/28/23 Fate Therapeutics reports Q4 EPS (58c), consensus (86c) GILD Gilead $77.88 / +1.665 (+2.18%) 05/15/23 Gilead: Arcus deal may reduce Gilead's FY23 GAAP and non-GAAP EPS by 2c 04/27/23 Gilead backs FY23 adjusted EPS view $6.60-$7.00, consensus $6.84 04/27/23 Gilead reports Q1 Biktarvy sales up 24% y/y 04/27/23 Gilead Sciences reports Q1 adjusted EPS $1.37, consensus $1.54 EFTR eFfector Therapeutics $1.17 / +0.13 (+12.50%) 05/09/23 eFfector Therapeutics reports Q1 EPS (24c), consensus (14c) 03/08/23 eFfector Therapeutics reports Q4 EPS (22c), consensus (24c) BMY Bristol-Myers $65.66 / +0.98 (+1.52%) 04/27/23 Bristol-Myers backs FY23 adjusted EPS view $7.95-$8.25, consensus $8.06 04/27/23 Bristol-Myers reports Q1 adjusted EPS $2.05, consensus $1.97 04/26/23 Notable companies reporting before tomorrow's open ARAV Aravive $1.80 / +0.04 (+2.27%) 05/10/23 Aravive reports Q1 EPS (66c), consensus (32c) 03/15/23 Aravive reports Q4 EPS (46c), consensus (30c) REGN NVS JNJ BMY REGN Regeneron $740.00 / +8.995 (+1.23%) 05/17/23 Regeneron CEO backs regulators attempt to block Amgen deal, FT reports NVS Novartis $98.90 / +1.79 (+1.84%) 04/14/23 FDA resuming China lab inspections could benefit Amicus, BeiGene, Barron's says 03/22/23 Novartis halts Leqvio heart attack prevention trial, Reuters reports 02/08/23 Avrobio exploring potential sale after approach, Street Insider says 12/29/22 Novartis to pay $245M to settle lawsuit on Exforge medicine, Bloomberg reports JNJ Johnson & Johnson $156.98 / +2.44 (+1.58%) 05/26/23 Health authorities to target next COVID shot to new strain, WSJ says 05/23/23 Amgen, J&J settle patent lawsuit over Stelara biosimilar, Reuters reports 05/10/23 New suitors showing interest in ShockWave Medical, Street Insider says 05/03/23 Johnson & Johnson's Kenvue to price at $22 per share, Bloomberg says BMY Bristol-Myers $65.66 / +0.98 (+1.52%) 01/04/23 Aurinia worth 'keeping closer eye on' after settlement, Dealreporter says REGN PDSB NVS JNJ IMAB GILD EFTR BMY REGN Regeneron $740.00 / +8.995 (+1.23%) 03/28/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/27/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/24/23 What You Missed On Wall Street On Friday 03/24/23 What You Missed On Wall Street This Morning PDSB PDS Biotechnology $9.40 / -0.5 (-5.05%) 01/03/23 What You Missed On Wall Street On Tuesday 01/03/23 What You Missed On Wall Street This Morning NVS Novartis $98.90 / +1.79 (+1.84%) 05/24/23 Biotech Alert: Searches spiking for these stocks today 05/22/23 Fly Intel: Pre-market Movers 03/22/23 What You Missed On Wall Street On Wednesday 03/22/23 What You Missed On Wall Street This Morning JNJ Johnson & Johnson $156.98 / +2.44 (+1.58%) 06/02/23 Buy/Sell: Wall Street's top 10 stock calls this week 05/30/23 What You Missed On Wall Street On Tuesday 05/30/23 What You Missed On Wall Street This Morning 05/30/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations IMAB I-Mab $3.18 / +0.145 (+4.78%) 05/25/23 Fly Intel: After-Hours Movers GILD Gilead $77.88 / +1.665 (+2.18%) 05/16/23 What You Missed On Wall Street On Tuesday 05/16/23 What You Missed On Wall Street This Morning 05/16/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/28/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations EFTR eFfector Therapeutics $1.17 / +0.13 (+12.50%) 05/26/23 What You Missed On Wall Street On Friday 05/26/23 What You Missed On Wall Street This Morning BMY Bristol-Myers $65.66 / +0.98 (+1.52%) 03/06/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/02/23 Fly Intel: Pre-market Movers 01/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/02/23 Biotechnology--Pre-ASCO Reception 06/09/23 Biotechnology 06/02/23 2023 ASCO Annual Meeting 07/27/23 Bristol-Myers - BMY 06/16/23 PDUFA Date for CAMZYOS 06/27/23 PDUFA Date for Eylea 08/20/23 PDUFA Date for Pozelimab 12/16/23 PDUFA Date for Abecma 06/09/23 Regeneron Pharmaceuticals 06/21/23 Mustang Bio Inc 06/22/23 eFFECTOR Therapeutics Inc REGN PDSB NVS JNJ GILD BMY REGN Regeneron $740.00 / +8.995 (+1.23%) 03/23/23 Early notable gainers among liquid option names on March 23rd PDSB PDS Biotechnology $9.40 / -0.5 (-5.05%) 12/13/22 Largest borrow rate increases among liquid names NVS Novartis $98.90 / +1.79 (+1.84%) 01/09/23 Novartis call volume above normal and directionally bullish 12/16/22 Novartis call volume above normal and directionally bullish JNJ Johnson & Johnson $156.98 / +2.44 (+1.58%) 04/18/23 Unusually active option classes on open April 18th 04/06/23 Unusually active option classes on open April 6th 04/05/23 Early notable gainers among liquid option names on April 5th 04/05/23 Unusually active option classes on open April 5th GILD Gilead $77.88 / +1.665 (+2.18%) 05/25/23 Gilead call volume above normal and directionally bullish 05/03/23 Gilead call volume above normal and directionally bullish 04/27/23 Gilead options imply 3.8% move in share price post-earnings 02/03/23 Early notable gainers among liquid option names on February 3rd BMY Bristol-Myers $65.66 / +0.98 (+1.52%) 03/10/23 Bristol Myers Squibb put volume heavy and directionally bearish 02/24/23 Bristol Myers Squibb put volume heavy and directionally bearish

Events

Earnings calls, analyst events, roadshows and more

Today at 18:00

Healthcare--Reception Industry Meetings

Chicago, IL
Tomorrow at 00:00

Truist Hosted Company Events at 2023 ASCO Annual Meeting Conferences

Chicago, IL
Tomorrow at 00:00

2023 ASCO Annual Meeting Conferences

Chicago, IL
Tomorrow at 00:00

Biotechnology--Dinner Industry Meetings

Chicago, IL
2023-06-05 at 00:00

2023 ASCO Annual Meeting Conferences

Chicago, IL
AXP ...
2023-06-05 at 00:00

FinTech Virtual Bus Tour Conferences

Virtual Tour
2023-06-05 at 00:00

Truist Hosted Company Events at 2023 ASCO Annual Meeting Conferences

Chicago, IL
HOOD
2023-06-05 at 00:00

Robinhood Firm Sponsored Meetings

Boston, MA
CCK
2023-06-05 at 00:00

Crown Holdings Firm Sponsored Meetings

Virtual Meeting
FVRR
2023-06-05 at 00:00

Fiverr Firm Sponsored Meetings

New York, NY

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	ASLE X ASLE AerSale Spot Secondary Managers: RBC Capital Priced at: $15.15 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLTE X BLTE Belite Bio Spot Secondary Managers: SVB Securities, Cantor Fitzgerald & H.C. Wainwright Priced at: $15.00 2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HRZN X HRZN Horizon Technology Spot Secondary Managers: Morgan Stanley, UBS & Wells Fargo Priced at: $12.50 3.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	OWL X OWL Blue Owl Capital Block Trade Managers: BofA Priced at: $10.15 7.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OCS X OCS Oculis Secondary Managers: BofA & SVB Securities, Wedbush, Baird, H.C. Wainwright, Pareto Priced at: $11.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LCID X LCID Lucid Group Spot Secondary Managers: BofA Priced at: $6.98 173.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LXRX X LXRX Lexicon Spot Secondary Managers: Citi, Jefferies & Piper Sandler Priced at: $2.60 23.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VNRX X VNRX VolitionRx Spot Secondary Managers: Freedom Capital Markets, Bancroft Capital Priced at: $1.27 13M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	MKSI X MKSI MKS Instruments Spot Secondary Managers: JPMorgan Priced at: $97.15 2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Simply Good Foods price target raised to $43 from $40 at Stephens

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access